data_2ldi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ldi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.401 0.62 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.041 0.448 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.417 0 CA-C-O 121.322 0.582 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp . . . . . 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.834 0.35 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.56 0.695 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.559 0.219 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -159.84 133.63 7.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.009 1.324 . . . . 0.0 111.422 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp -72.43 -23.82 61.13 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -60.34 159.32 10.26 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m 72.46 7.13 5.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.353 1.861 . . . . 0.0 115.503 159.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.37 165.61 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.995 1.718 . . . . 0.0 110.898 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -1.45 4.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.82 -31.5 17.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 0.0 114.727 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 CA--C 1.537 0.666 0 N-CA-C 114.899 1.076 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.88 154.78 0.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.809 2.444 . . . . 0.0 116.898 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp -69.33 -19.76 63.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -55.98 142.87 34.27 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.24 0.927 . . . . 0.0 112.065 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m 93.28 138.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.326 3.451 . . . . 0.0 110.316 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.16 75.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.09 73.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.53 -0.731 . . . . 0.0 112.913 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -81.2 -45.43 16.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 112.485 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 CA--C 1.534 0.522 0 N-CA-C 112.697 0.23 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.59 138.31 44.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -66.89 -15.37 63.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -62.74 15.07 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.7 t -80.42 139.99 36.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.375 -1.453 . . . . 0.0 109.855 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.66 -4.17 2.81 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.89 5.24 12.17 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.854 1.662 . . . . 0.0 113.969 173.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m -115.11 -43.25 3.1 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 CA--C 1.537 0.647 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.04 -144.48 0.14 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.661 1.584 . . . . 0.0 111.91 -170.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.29 127.3 33.54 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -148.56 -22.23 0.32 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.119 1.768 . . . . 0.0 115.137 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 p -104.82 162.72 13.07 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.439 1.472 . . . . 0.0 114.484 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.39 86.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.737 1.615 . . . . 0.0 112.744 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.24 74.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.156 0.582 . . . . 0.0 111.461 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m -68.63 -40.89 80.1 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 112.406 0.118 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -66.28 149.07 50.91 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.707 0.803 . . . . 0.0 112.305 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp -118.0 3.57 12.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.98 55.77 0.19 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.804 1.642 . . . . 0.0 113.677 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.4 t -153.52 130.26 10.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.168 2.187 . . . . 0.0 110.054 -175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.24 71.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.917 1.287 . . . . 0.0 113.095 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.79 91.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.611 0.765 . . . . 0.0 111.807 172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m -75.59 -42.27 52.4 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.327 1.051 . . . . 0.0 112.582 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 CA--C 1.534 0.477 0 N-CA-C 114.207 0.81 . . . . 0.0 114.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.72 149.28 38.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.622 1.969 . . . . 0.0 115.05 -175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp -73.32 -19.24 61.08 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -67.89 91.82 0.34 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.437 2.295 . . . . 0.0 110.196 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t 175.92 149.8 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.708 2.803 . . . . 0.0 109.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 122.1 10.71 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.1 -6.56 1.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.634 2.774 . . . . 0.0 114.605 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.36 -23.01 66.27 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -162.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 119.257 -0.393 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 133.54 34.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.516 0.598 . . . . 0.0 111.166 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp -81.6 114.93 20.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 178.43 131.34 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.601 2.761 . . . . 0.0 109.087 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m 61.66 166.09 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.928 1.691 . . . . 0.0 113.101 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.8 -172.24 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.613 1.565 . . . . 0.0 114.085 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.35 -8.07 59.48 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -168.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -55.62 -31.4 62.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo . . . . . 0 N--CA 1.48 0.732 0 N-CA-C 112.365 0.102 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -169.41 156.53 6.84 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.212 1.405 . . . . 0.0 111.464 -169.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm -64.22 -14.06 53.03 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -72.8 -7.64 51.67 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.954 1.706 . . . . 0.0 114.673 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -52.62 -23.64 6.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.84 -161.94 0.96 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.243 2.217 . . . . 0.0 109.443 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.64 11.99 0.42 Allowed 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.0 -25.6 44.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -163.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.472 0.214 0 CA-C-O 119.494 -0.294 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.95 135.22 56.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.6 0.76 . . . . 0.0 111.89 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp -88.35 3.09 51.04 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -54.49 138.52 40.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.451 1.1 . . . . 0.0 111.651 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.9 m 90.11 149.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 129.25 3.02 . . . . 0.0 113.31 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.16 84.07 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.59 66.91 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.302 -0.874 . . . . 0.0 112.801 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m -92.21 -46.02 7.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.701 1.6 . . . . 0.0 111.975 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.436 0.514 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -56.77 142.59 40.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.324 1.05 . . . . 0.0 113.136 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -9.06 50.52 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.1 mtp85 -60.31 140.53 57.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.016 1.326 . . . . 0.0 112.62 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m 75.23 8.02 4.02 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.16 2.584 . . . . 0.0 114.327 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.02 16.25 10.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.732 1.613 . . . . 0.0 114.421 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.93 -7.84 0.59 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.627 2.371 . . . . 0.0 114.776 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.21 -22.79 67.1 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.443 -1.411 . . . . 0.0 114.575 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 N-CA-C 113.265 0.448 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -70.15 152.32 44.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.146 0.578 . . . . 0.0 112.145 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp -67.88 110.96 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -176.49 -14.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.11 165.05 24.45 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 173.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.28 144.9 44.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.389 0.676 . . . . 0.0 112.339 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.95 14.77 6.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.199 1.8 . . . . 0.0 114.702 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m -84.55 -18.77 34.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.48 0.693 0 N-CA-C 113.1 0.384 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.27 150.1 48.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.599 1.56 . . . . 0.0 110.725 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.07 -21.67 65.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -63.2 7.27 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.1 p -85.35 -155.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.521 1.929 . . . . 0.0 113.241 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -75.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.49 -10.77 19.08 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -164.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t -60.62 -31.5 70.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.417 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -85.02 161.24 19.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.223 0.609 . . . . 0.0 110.333 169.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -56.53 -17.11 7.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -62.09 -12.68 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.5 m -53.38 155.14 2.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.544 1.138 . . . . 0.0 112.531 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 114.52 1.42 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.584 1.154 . . . . 0.0 112.997 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.56 -2.17 0.89 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.983 2.513 . . . . 0.0 115.557 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -67.38 -31.09 71.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.451 1.478 . . . . 0.0 112.877 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 113.542 0.555 . . . . 0.0 113.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -110.2 141.03 43.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.536 1.535 . . . . 0.0 110.133 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt -116.43 -33.55 4.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -68.06 -18.02 64.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.6 t -97.03 128.9 44.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.865 1.266 . . . . 0.0 110.074 163.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.02 84.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.73 72.06 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.456 -0.777 . . . . 0.0 112.793 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -74.41 -50.88 16.75 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.025 -1.047 . . . . 0.0 112.061 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.536 0.59 0 N-CA-C 113.706 0.618 . . . . 0.0 113.706 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.43 154.02 46.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.946 1.298 . . . . 0.0 112.044 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -0.63 13.68 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -64.87 72.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.16 2.184 . . . . 0.0 115.079 -168.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -157.66 138.27 12.99 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.507 2.323 . . . . 0.0 109.783 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.89 67.75 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.6 -32.7 31.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m -76.7 -32.98 58.22 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.049 -1.032 . . . . 0.0 112.983 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 CA--C 1.531 0.326 0 N-CA-C 112.699 0.231 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.09 146.72 24.64 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.59 0.756 . . . . 0.0 112.26 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm -64.46 -25.93 68.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -84.84 166.73 16.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.697 1.199 . . . . 0.0 112.418 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m 67.64 35.13 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.207 2.203 . . . . 0.0 110.261 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 174.21 166.67 0.22 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 130.721 3.608 . . . . 0.0 110.656 -167.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.84 7.03 25.49 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m -63.84 -25.38 68.14 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.316 -1.49 . . . . 0.0 115.016 -163.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 CA--C 1.534 0.491 0 CA-C-O 120.342 0.059 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.42 136.46 57.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.13 137.79 58.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 68.27 0.31 2.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.664 1.985 . . . . 0.0 115.423 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.09 -24.81 8.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.779 1.632 . . . . 0.0 113.253 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.11 6.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.519 1.927 . . . . 0.0 109.777 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 18.19 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.256 1.422 . . . . 0.0 114.327 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -53.11 -31.01 39.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.227 1.811 . . . . 0.0 115.561 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 112.743 0.247 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.65 45.85 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.245 1.418 . . . . 0.0 111.186 -169.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp -71.26 3.72 3.41 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -66.89 41.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 129.3 3.04 . . . . 0.0 115.552 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 45.5 t -155.01 139.41 16.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.924 2.09 . . . . 0.0 108.966 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.88 74.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.748 0.819 . . . . 0.0 113.178 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.85 73.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.282 0.633 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.88 -32.6 27.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 CA--C 1.538 0.683 0 N-CA-C 112.765 0.256 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -158.07 155.18 28.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.504 1.121 . . . . 0.0 111.555 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp -87.43 126.6 34.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 167.06 156.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.602 2.761 . . . . 0.0 110.763 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m 75.05 -58.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.804 2.442 . . . . 0.0 114.172 168.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.51 145.36 12.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.126 1.37 . . . . 0.0 112.494 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.69 -166.15 0.15 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.823 2.449 . . . . 0.0 115.138 166.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m 76.64 -30.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.804 2.441 . . . . 0.0 115.661 159.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.536 0.581 0 CA-C-O 120.905 0.294 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.22 178.58 6.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 112.955 -170.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm -122.47 -0.69 9.21 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.2 ptt85 -153.87 -15.46 0.14 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -165.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -83.16 -24.26 32.58 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 0.0 112.98 172.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.85 175.76 7.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.014 2.126 . . . . 0.0 111.552 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 25.9 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.406 2.282 . . . . 0.0 115.805 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.38 -11.9 60.63 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 CA--C 1.537 0.668 0 N-CA-C 114.028 0.741 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.23 162.64 29.18 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.414 1.086 . . . . 0.0 111.343 178.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt -63.44 -22.82 67.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -71.41 -18.15 62.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.304 1.411 . . . . 0.0 113.943 171.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.19 163.3 19.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.861 1.265 . . . . 0.0 112.543 -171.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.13 120.93 5.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.332 1.453 . . . . 0.0 113.273 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 6.86 1.42 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 115.404 174.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.13 -37.31 75.27 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.898 -1.126 . . . . 0.0 113.815 -168.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.73 142.03 49.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 113.547 177.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -101.15 122.82 44.29 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -162.71 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.358 1.463 . . . . 0.0 113.148 176.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.95 143.32 46.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.333 1.453 . . . . 0.0 110.768 173.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.73 -30.54 68.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.459 -0.776 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.74 58.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 173.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t -117.42 -21.37 8.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 N--CA 1.48 0.729 0 CA-C-O 118.995 -0.502 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.43 146.23 47.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.138 0.881 . . . . 0.0 112.072 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp -70.76 116.34 10.96 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -134.47 178.22 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.07 1.748 . . . . 0.0 110.985 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.9 -50.1 73.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.361 1.464 . . . . 0.0 114.5 -170.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.65 -40.45 69.03 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -158.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.42 -36.15 0.19 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -55.58 -49.5 72.56 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.283 0.947 . . . . 0.0 112.706 -174.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 119.503 -0.291 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.93 164.46 12.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.612 1.165 . . . . 0.0 113.487 173.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -89.82 147.23 23.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -149.0 177.07 9.9 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.516 2.327 . . . . 0.0 110.704 176.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.23 -54.2 49.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.742 1.217 . . . . 0.0 112.335 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.55 118.94 8.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.005 0.522 . . . . 0.0 110.754 177.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.46 -66.65 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.451 2.3 . . . . 0.0 113.691 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.62 -52.27 65.85 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.194 0.906 . . . . 0.0 112.89 -160.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.478 0.591 0 CA-C-O 120.084 -0.048 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -54.43 142.21 27.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.453 0.701 . . . . 0.0 112.198 168.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -78.55 9.47 3.99 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.91 160.0 19.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.714 1.143 . . . . 0.0 111.841 173.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.9 t 72.63 -73.91 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.28 2.232 . . . . 0.0 112.735 170.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -174.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.328 2.251 . . . . 0.0 113.868 -172.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.84 9.58 7.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.734 1.613 . . . . 0.0 114.658 174.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m -53.12 -42.48 66.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.154 1.782 . . . . 0.0 114.668 -174.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 CA-C-O 119.886 -0.131 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.04 147.16 43.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp -81.2 119.43 23.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -171.47 12.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.452 1.901 . . . . 0.0 115.283 178.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.37 155.24 28.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.992 1.317 . . . . 0.0 111.677 164.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.56 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.12 -56.36 21.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.053 0.941 . . . . 0.0 111.838 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p -66.93 -42.82 84.69 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.462 -0.774 . . . . 0.0 112.64 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 112.655 0.213 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -158.11 138.15 12.37 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.365 1.466 . . . . 0.0 110.463 -177.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt -90.01 2.32 55.3 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -67.22 24.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 t -141.84 126.63 18.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.885 2.474 . . . . 0.0 109.601 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.26 82.6 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.745 1.218 . . . . 0.0 112.658 -173.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.96 -25.72 61.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.027 0.931 . . . . 0.0 113.347 171.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m -96.34 -34.64 11.5 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.985 0.914 . . . . 0.0 113.091 177.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 120.158 -0.018 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.96 150.37 24.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 173.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.71 -12.98 19.01 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.99 57.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.057 2.943 . . . . 0.0 115.819 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.36 143.76 17.95 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.111 1.764 . . . . 0.0 109.169 168.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.18 66.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -167.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.05 96.43 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.714 -0.616 . . . . 0.0 111.681 176.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m -67.88 -48.38 66.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.764 0.826 . . . . 0.0 112.939 -174.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 113.644 0.594 . . . . 0.0 113.644 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp -107.69 -172.09 2.0 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.249 1.82 . . . . 0.0 110.585 172.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.46 -30.36 64.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -45.99 113.96 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.359 1.063 . . . . 0.0 113.527 -174.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.9 m 58.56 24.87 12.45 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.529 1.931 . . . . 0.0 114.452 173.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.92 21.81 2.46 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -167.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.04 -4.63 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.6 5.56 0.29 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 112.82 0.277 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -154.22 152.05 29.89 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.26 1.024 . . . . 0.0 111.86 -176.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.35 -9.22 52.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -105.74 -11.48 16.27 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.346 0.976 . . . . 0.0 113.512 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.99 -19.69 64.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.961 1.304 . . . . 0.0 113.965 174.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.14 155.4 20.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.389 2.276 . . . . 0.0 108.48 172.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.69 102.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.252 0.933 . . . . 0.0 111.059 177.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m -137.8 -4.97 1.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.07 1.748 . . . . 0.0 114.77 -170.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.401 0.62 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.446 HD11 ' NE ' ' A' ' 65' ' ' ARG . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NE ' HD11 ' A' ' 33' ' ' LEU . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 57' ' ' VAL . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 34' ' ' LYS . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.041 0.448 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.417 0 CA-C-O 121.322 0.582 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HE2' ' CG ' ' A' ' 52' ' ' TYR . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CG ' ' HE2' ' A' ' 34' ' ' LYS . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD13 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 48' ' ' LEU . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp . . . . . 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.42 HG21 ' HB1' ' A' ' 23' ' ' ALA . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.834 0.35 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 23' ' ' ALA . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.56 0.695 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 23' ' ' ALA . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.559 0.219 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 43' ' ' VAL . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 23' ' ' ALA . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -159.84 133.63 7.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.009 1.324 . . . . 0.0 111.422 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp -72.43 -23.82 61.13 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -60.34 159.32 10.26 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m 72.46 7.13 5.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.353 1.861 . . . . 0.0 115.503 159.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.37 165.61 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.995 1.718 . . . . 0.0 110.898 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -1.45 4.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.82 -31.5 17.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 0.0 114.727 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 CA--C 1.537 0.666 0 N-CA-C 114.899 1.076 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.88 154.78 0.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.809 2.444 . . . . 0.0 116.898 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp -69.33 -19.76 63.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -55.98 142.87 34.27 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.24 0.927 . . . . 0.0 112.065 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m 93.28 138.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.326 3.451 . . . . 0.0 110.316 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.16 75.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.09 73.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.53 -0.731 . . . . 0.0 112.913 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -81.2 -45.43 16.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 112.485 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.446 HD11 ' NE ' ' A' ' 65' ' ' ARG . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NE ' HD11 ' A' ' 33' ' ' LEU . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 CA--C 1.534 0.522 0 N-CA-C 112.697 0.23 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.59 138.31 44.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -66.89 -15.37 63.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -62.74 15.07 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.7 t -80.42 139.99 36.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.375 -1.453 . . . . 0.0 109.855 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.66 -4.17 2.81 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.89 5.24 12.17 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.854 1.662 . . . . 0.0 113.969 173.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m -115.11 -43.25 3.1 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 CA--C 1.537 0.647 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.04 -144.48 0.14 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.661 1.584 . . . . 0.0 111.91 -170.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.29 127.3 33.54 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -148.56 -22.23 0.32 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.119 1.768 . . . . 0.0 115.137 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 p -104.82 162.72 13.07 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.439 1.472 . . . . 0.0 114.484 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.39 86.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.737 1.615 . . . . 0.0 112.744 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.24 74.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.156 0.582 . . . . 0.0 111.461 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m -68.63 -40.89 80.1 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 112.406 0.118 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -66.28 149.07 50.91 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.707 0.803 . . . . 0.0 112.305 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp -118.0 3.57 12.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.98 55.77 0.19 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.804 1.642 . . . . 0.0 113.677 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.4 t -153.52 130.26 10.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.168 2.187 . . . . 0.0 110.054 -175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.24 71.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.917 1.287 . . . . 0.0 113.095 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.79 91.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.611 0.765 . . . . 0.0 111.807 172.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m -75.59 -42.27 52.4 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.327 1.051 . . . . 0.0 112.582 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 CA--C 1.534 0.477 0 N-CA-C 114.207 0.81 . . . . 0.0 114.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.462 ' CD2' ' H ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -75.72 149.28 38.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.622 1.969 . . . . 0.0 115.05 -175.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp -73.32 -19.24 61.08 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -67.89 91.82 0.34 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.437 2.295 . . . . 0.0 110.196 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t 175.92 149.8 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.708 2.803 . . . . 0.0 109.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 122.1 10.71 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.1 -6.56 1.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.634 2.774 . . . . 0.0 114.605 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.36 -23.01 66.27 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -162.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 57' ' ' VAL . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 34' ' ' LYS . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 119.257 -0.393 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -84.0 133.54 34.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.516 0.598 . . . . 0.0 111.166 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp -81.6 114.93 20.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 178.43 131.34 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.601 2.761 . . . . 0.0 109.087 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m 61.66 166.09 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.928 1.691 . . . . 0.0 113.101 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.8 -172.24 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.613 1.565 . . . . 0.0 114.085 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.35 -8.07 59.48 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -168.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -55.62 -31.4 62.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo . . . . . 0 N--CA 1.48 0.732 0 N-CA-C 112.365 0.102 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -169.41 156.53 6.84 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.212 1.405 . . . . 0.0 111.464 -169.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm -64.22 -14.06 53.03 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -72.8 -7.64 51.67 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.954 1.706 . . . . 0.0 114.673 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -52.62 -23.64 6.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.84 -161.94 0.96 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.243 2.217 . . . . 0.0 109.443 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.64 11.99 0.42 Allowed 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.0 -25.6 44.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -163.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.472 0.214 0 CA-C-O 119.494 -0.294 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.95 135.22 56.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.6 0.76 . . . . 0.0 111.89 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp -88.35 3.09 51.04 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -54.49 138.52 40.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.451 1.1 . . . . 0.0 111.651 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.9 m 90.11 149.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 129.25 3.02 . . . . 0.0 113.31 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.16 84.07 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.59 66.91 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.302 -0.874 . . . . 0.0 112.801 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m -92.21 -46.02 7.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.701 1.6 . . . . 0.0 111.975 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.436 0.514 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -56.77 142.59 40.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.324 1.05 . . . . 0.0 113.136 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -9.06 50.52 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.1 mtp85 -60.31 140.53 57.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.016 1.326 . . . . 0.0 112.62 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m 75.23 8.02 4.02 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.16 2.584 . . . . 0.0 114.327 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.02 16.25 10.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.732 1.613 . . . . 0.0 114.421 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.93 -7.84 0.59 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.627 2.371 . . . . 0.0 114.776 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.21 -22.79 67.1 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.443 -1.411 . . . . 0.0 114.575 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 N-CA-C 113.265 0.448 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -70.15 152.32 44.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.146 0.578 . . . . 0.0 112.145 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp -67.88 110.96 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -176.49 -14.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.11 165.05 24.45 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 173.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.28 144.9 44.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.389 0.676 . . . . 0.0 112.339 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.95 14.77 6.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.199 1.8 . . . . 0.0 114.702 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m -84.55 -18.77 34.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.48 0.693 0 N-CA-C 113.1 0.384 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.27 150.1 48.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.599 1.56 . . . . 0.0 110.725 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.07 -21.67 65.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -63.2 7.27 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.1 p -85.35 -155.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.521 1.929 . . . . 0.0 113.241 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -75.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.49 -10.77 19.08 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -164.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t -60.62 -31.5 70.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HE2' ' CG ' ' A' ' 52' ' ' TYR . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CG ' ' HE2' ' A' ' 34' ' ' LYS . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.417 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -85.02 161.24 19.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.223 0.609 . . . . 0.0 110.333 169.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -56.53 -17.11 7.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -62.09 -12.68 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.5 m -53.38 155.14 2.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.544 1.138 . . . . 0.0 112.531 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 114.52 1.42 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.584 1.154 . . . . 0.0 112.997 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.56 -2.17 0.89 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.983 2.513 . . . . 0.0 115.557 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -67.38 -31.09 71.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.451 1.478 . . . . 0.0 112.877 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 113.542 0.555 . . . . 0.0 113.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.3 pt? -110.2 141.03 43.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.536 1.535 . . . . 0.0 110.133 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt -116.43 -33.55 4.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -68.06 -18.02 64.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.6 t -97.03 128.9 44.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.865 1.266 . . . . 0.0 110.074 163.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.02 84.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.73 72.06 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.456 -0.777 . . . . 0.0 112.793 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -74.41 -50.88 16.75 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.025 -1.047 . . . . 0.0 112.061 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.536 0.59 0 N-CA-C 113.706 0.618 . . . . 0.0 113.706 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.43 154.02 46.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.946 1.298 . . . . 0.0 112.044 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -0.63 13.68 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -64.87 72.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.16 2.184 . . . . 0.0 115.079 -168.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -157.66 138.27 12.99 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.507 2.323 . . . . 0.0 109.783 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.89 67.75 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.6 -32.7 31.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m -76.7 -32.98 58.22 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.049 -1.032 . . . . 0.0 112.983 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 CA--C 1.531 0.326 0 N-CA-C 112.699 0.231 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.09 146.72 24.64 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.59 0.756 . . . . 0.0 112.26 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm -64.46 -25.93 68.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -84.84 166.73 16.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.697 1.199 . . . . 0.0 112.418 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m 67.64 35.13 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.207 2.203 . . . . 0.0 110.261 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 174.21 166.67 0.22 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 130.721 3.608 . . . . 0.0 110.656 -167.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.84 7.03 25.49 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m -63.84 -25.38 68.14 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.316 -1.49 . . . . 0.0 115.016 -163.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 CA--C 1.534 0.491 0 CA-C-O 120.342 0.059 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.42 136.46 57.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.13 137.79 58.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 68.27 0.31 2.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.664 1.985 . . . . 0.0 115.423 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.09 -24.81 8.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.779 1.632 . . . . 0.0 113.253 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.11 6.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.519 1.927 . . . . 0.0 109.777 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 18.19 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.256 1.422 . . . . 0.0 114.327 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -53.11 -31.01 39.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.227 1.811 . . . . 0.0 115.561 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD13 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 48' ' ' LEU . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 112.743 0.247 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.65 45.85 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.245 1.418 . . . . 0.0 111.186 -169.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp -71.26 3.72 3.41 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -66.89 41.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 129.3 3.04 . . . . 0.0 115.552 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 45.5 t -155.01 139.41 16.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.924 2.09 . . . . 0.0 108.966 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.88 74.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.748 0.819 . . . . 0.0 113.178 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.85 73.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.282 0.633 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.88 -32.6 27.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 CA--C 1.538 0.683 0 N-CA-C 112.765 0.256 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -158.07 155.18 28.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.504 1.121 . . . . 0.0 111.555 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp -87.43 126.6 34.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 167.06 156.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.602 2.761 . . . . 0.0 110.763 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m 75.05 -58.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.804 2.442 . . . . 0.0 114.172 168.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.51 145.36 12.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.126 1.37 . . . . 0.0 112.494 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.69 -166.15 0.15 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.823 2.449 . . . . 0.0 115.138 166.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m 76.64 -30.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.804 2.441 . . . . 0.0 115.661 159.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.42 HG21 ' HB1' ' A' ' 23' ' ' ALA . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.536 0.581 0 CA-C-O 120.905 0.294 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.22 178.58 6.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 112.955 -170.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm -122.47 -0.69 9.21 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.2 ptt85 -153.87 -15.46 0.14 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -165.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -83.16 -24.26 32.58 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 0.0 112.98 172.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.85 175.76 7.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.014 2.126 . . . . 0.0 111.552 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 25.9 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.406 2.282 . . . . 0.0 115.805 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.38 -11.9 60.63 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 CA--C 1.537 0.668 0 N-CA-C 114.028 0.741 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.23 162.64 29.18 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.414 1.086 . . . . 0.0 111.343 178.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt -63.44 -22.82 67.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -71.41 -18.15 62.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.304 1.411 . . . . 0.0 113.943 171.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.19 163.3 19.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.861 1.265 . . . . 0.0 112.543 -171.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.13 120.93 5.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.332 1.453 . . . . 0.0 113.273 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 6.86 1.42 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 115.404 174.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.13 -37.31 75.27 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.898 -1.126 . . . . 0.0 113.815 -168.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.1 pt? -71.73 142.03 49.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 113.547 177.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -101.15 122.82 44.29 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -162.71 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.358 1.463 . . . . 0.0 113.148 176.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.95 143.32 46.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.333 1.453 . . . . 0.0 110.768 173.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.73 -30.54 68.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.459 -0.776 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.74 58.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 173.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t -117.42 -21.37 8.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 N--CA 1.48 0.729 0 CA-C-O 118.995 -0.502 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.43 146.23 47.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.138 0.881 . . . . 0.0 112.072 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp -70.76 116.34 10.96 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -134.47 178.22 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.07 1.748 . . . . 0.0 110.985 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.9 -50.1 73.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.361 1.464 . . . . 0.0 114.5 -170.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.65 -40.45 69.03 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -158.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.42 -36.15 0.19 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -55.58 -49.5 72.56 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.283 0.947 . . . . 0.0 112.706 -174.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 119.503 -0.291 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.93 164.46 12.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.612 1.165 . . . . 0.0 113.487 173.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -89.82 147.23 23.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -149.0 177.07 9.9 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.516 2.327 . . . . 0.0 110.704 176.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.23 -54.2 49.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.742 1.217 . . . . 0.0 112.335 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.55 118.94 8.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.005 0.522 . . . . 0.0 110.754 177.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.46 -66.65 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.451 2.3 . . . . 0.0 113.691 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.62 -52.27 65.85 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.194 0.906 . . . . 0.0 112.89 -160.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 23' ' ' ALA . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.478 0.591 0 CA-C-O 120.084 -0.048 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -54.43 142.21 27.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.453 0.701 . . . . 0.0 112.198 168.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -78.55 9.47 3.99 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.91 160.0 19.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.714 1.143 . . . . 0.0 111.841 173.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.9 t 72.63 -73.91 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.28 2.232 . . . . 0.0 112.735 170.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -174.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.328 2.251 . . . . 0.0 113.868 -172.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.84 9.58 7.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.734 1.613 . . . . 0.0 114.658 174.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m -53.12 -42.48 66.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.154 1.782 . . . . 0.0 114.668 -174.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 CA-C-O 119.886 -0.131 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.04 147.16 43.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp -81.2 119.43 23.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -171.47 12.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.452 1.901 . . . . 0.0 115.283 178.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.37 155.24 28.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.992 1.317 . . . . 0.0 111.677 164.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.56 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.12 -56.36 21.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.053 0.941 . . . . 0.0 111.838 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p -66.93 -42.82 84.69 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.462 -0.774 . . . . 0.0 112.64 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 23' ' ' ALA . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 112.655 0.213 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -158.11 138.15 12.37 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.365 1.466 . . . . 0.0 110.463 -177.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt -90.01 2.32 55.3 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -67.22 24.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 t -141.84 126.63 18.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.885 2.474 . . . . 0.0 109.601 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.26 82.6 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.745 1.218 . . . . 0.0 112.658 -173.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.96 -25.72 61.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.027 0.931 . . . . 0.0 113.347 171.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m -96.34 -34.64 11.5 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.985 0.914 . . . . 0.0 113.091 177.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 120.158 -0.018 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.96 150.37 24.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 173.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.71 -12.98 19.01 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.99 57.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.057 2.943 . . . . 0.0 115.819 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.36 143.76 17.95 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.111 1.764 . . . . 0.0 109.169 168.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.18 66.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -167.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.05 96.43 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.714 -0.616 . . . . 0.0 111.681 176.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m -67.88 -48.38 66.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.764 0.826 . . . . 0.0 112.939 -174.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 113.644 0.594 . . . . 0.0 113.644 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp -107.69 -172.09 2.0 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.249 1.82 . . . . 0.0 110.585 172.097 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.46 -30.36 64.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -45.99 113.96 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.359 1.063 . . . . 0.0 113.527 -174.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.9 m 58.56 24.87 12.45 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.529 1.931 . . . . 0.0 114.452 173.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.92 21.81 2.46 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -167.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.04 -4.63 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.6 5.56 0.29 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 43' ' ' VAL . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 23' ' ' ALA . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 112.82 0.277 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -154.22 152.05 29.89 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.26 1.024 . . . . 0.0 111.86 -176.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.35 -9.22 52.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -105.74 -11.48 16.27 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.346 0.976 . . . . 0.0 113.512 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.99 -19.69 64.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.961 1.304 . . . . 0.0 113.965 174.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.14 155.4 20.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.389 2.276 . . . . 0.0 108.48 172.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.69 102.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.252 0.933 . . . . 0.0 111.059 177.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m -137.8 -4.97 1.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.07 1.748 . . . . 0.0 114.77 -170.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.401 0.62 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.446 HD11 ' NE ' ' A' ' 65' ' ' ARG . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NE ' HD11 ' A' ' 33' ' ' LEU . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 57' ' ' VAL . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 34' ' ' LYS . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.268 0.556 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.908 0.385 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.041 0.448 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.417 0 CA-C-O 121.322 0.582 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HE2' ' CG ' ' A' ' 52' ' ' TYR . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CG ' ' HE2' ' A' ' 34' ' ' LYS . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD13 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 48' ' ' LEU . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp . . . . . 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.42 HG21 ' HB1' ' A' ' 23' ' ' ALA . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.834 0.35 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? . . . . . 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.237 0.422 0 CA-C-O 121.73 0.776 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm . . . . . 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 23' ' ' ALA . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.56 0.695 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp . . . . . 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 23' ' ' ALA . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.559 0.219 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 N--CA 1.464 0.267 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m . . . . . 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 43' ' ' VAL . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 23' ' ' ALA . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -159.84 133.63 7.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.009 1.324 . . . . 0.0 111.422 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -138.74 153.58 48.49 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.264 1.026 . . . . 0.0 112.853 -167.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -67.46 156.99 35.27 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.79 1.636 . . . . 0.0 111.793 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -159.06 144.74 16.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.149 2.18 . . . . 0.0 106.469 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -138.1 152.99 49.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.365 0.602 . . . . 0.0 110.762 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.24 152.12 32.82 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.746 0.818 . . . . 0.0 112.42 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -82.78 154.6 24.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.604 161.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -144.06 126.47 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 109.61 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.84 107.01 2.36 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.98 2.77 59.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.911 -1.494 . . . . 0.0 116.738 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.9 ttp -72.43 -23.82 61.13 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.969 2.385 . . . . 0.0 114.027 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -60.34 159.32 10.26 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m 72.46 7.13 5.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.353 1.861 . . . . 0.0 115.503 159.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.37 165.61 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.995 1.718 . . . . 0.0 110.898 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -1.45 4.95 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.82 -31.5 17.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.453 2.301 . . . . 0.0 114.727 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.43 -30.92 8.77 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.951 1.3 . . . . 0.0 113.432 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.9 p -67.62 -22.5 65.34 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.747 -1.22 . . . . 0.0 113.635 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -75.47 -15.46 60.42 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.363 -1.461 . . . . 0.0 111.798 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mm -94.74 -45.43 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.314 1.446 . . . . 0.0 110.78 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -85.16 -24.76 27.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.589 1.156 . . . . 0.0 113.212 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.05 -41.42 99.48 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.343 0.974 . . . . 0.0 111.446 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.18 -29.89 71.15 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -35.47 -53.81 0.67 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.079 1.352 . . . . 0.0 113.564 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -76.16 -1.32 25.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -100.6 -28.42 12.88 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.167 1.387 . . . . 0.0 111.94 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.61 148.95 22.73 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.963 1.705 . . . . 0.0 113.178 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -91.25 145.18 24.87 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.385 1.074 . . . . 0.0 110.748 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.26 11.54 66.79 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 117.732 -1.593 . . . . 0.0 116.462 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.21 172.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 119.903 1.852 . . . . 0.0 112.526 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.14 -16.42 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -165.85 149.61 7.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.83 1.195 . . . . 0.0 109.069 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 165.99 20.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.716 1.206 . . . . 0.0 112.118 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -162.02 112.62 1.6 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.123 -0.986 . . . . 0.0 113.523 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.92 152.19 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.54 0.736 . . . . 0.0 112.537 172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 t -128.29 113.46 15.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.367 1.067 . . . . 0.0 108.421 160.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.07 -30.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.672 1.589 . . . . 0.0 110.023 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.35 -49.8 71.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.907 1.283 . . . . 0.0 112.031 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -96.14 -30.22 13.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.509 1.923 . . . . 0.0 112.921 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 51.26 3.37 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 125.335 1.445 . . . . 0.0 113.227 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -135.27 171.97 13.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.36 149.32 37.56 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.553 0.741 . . . . 0.0 111.947 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -124.22 141.97 51.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.921 1.688 . . . . 0.0 108.503 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 141.02 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.495 1.518 . . . . 0.0 110.738 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.8 m -112.14 118.99 36.88 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 109.634 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -144.5 161.96 37.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.916 1.286 . . . . 0.0 114.112 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -87.03 107.43 14.32 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.336 2.254 . . . . 0.0 108.476 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.17 4.89 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.561 2.841 . . . . 0.0 113.192 -170.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -116.68 -39.7 3.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.436 1.095 . . . . 0.0 111.874 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -67.02 -35.45 79.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.611 167.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.18 -175.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p -148.09 -165.89 2.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.959 1.304 . . . . 0.0 110.829 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.75 -20.73 0.51 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.819 0.848 . . . . 0.0 113.131 164.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.03 -24.4 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 119.854 -1.779 . . . . 0.0 114.152 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.8 m -80.82 0.73 33.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.432 -1.418 . . . . 0.0 112.949 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -128.55 -21.4 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.13 -55.3 22.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.644 1.178 . . . . 0.0 113.467 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.38 -42.93 98.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.882 0.764 . . . . 0.0 110.282 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -62.49 -10.49 11.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.722 2.409 . . . . 0.0 114.52 174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.56 -43.86 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.633 1.173 . . . . 0.0 110.201 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.84 -37.3 79.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 113.703 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.27 -23.15 35.42 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.682 1.193 . . . . 0.0 113.174 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.2 -7.08 57.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.531 1.133 . . . . 0.0 113.254 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.31 15.96 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 125.671 1.605 . . . . 0.0 115.491 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -123.4 -173.18 2.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.177 1.791 . . . . 0.0 111.324 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 p -136.9 143.11 42.79 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.062 -1.024 . . . . 0.0 112.018 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.1 tp -88.28 141.38 28.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.32 1.848 . . . . 0.0 111.296 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -133.64 106.9 7.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.251 1.421 . . . . 0.0 111.383 168.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.02 87.03 47.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 125.0 1.32 . . . . 0.0 108.508 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.801 3.667 . . . . 0.0 114.66 -173.423 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 CA--C 1.537 0.666 0 N-CA-C 114.899 1.076 . . . . 0.0 114.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.88 154.78 0.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.809 2.444 . . . . 0.0 116.898 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -143.51 129.33 19.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.388 1.475 . . . . 0.0 112.011 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -73.61 148.64 42.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.862 1.665 . . . . 0.0 112.842 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -162.68 158.65 23.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.15 1.38 . . . . 0.0 109.773 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -143.16 154.73 44.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.947 1.299 . . . . 0.0 109.904 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 ptm -161.71 166.76 26.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -157.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -107.78 164.93 11.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.678 1.591 . . . . 0.0 109.682 174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.11 137.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.118 1.367 . . . . 0.0 110.536 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.69 120.66 5.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.655 1.598 . . . . 0.0 110.966 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 -15.31 63.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.043 2.259 . . . . 0.0 116.079 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.6 ttp -69.33 -19.76 63.87 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.298 2.049 . . . . 0.0 113.981 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -55.98 142.87 34.27 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.24 0.927 . . . . 0.0 112.065 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m 93.28 138.09 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 130.326 3.451 . . . . 0.0 110.316 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.16 75.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.09 73.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.53 -0.731 . . . . 0.0 112.913 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -81.2 -45.43 16.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 112.485 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -29.37 58.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.564 0.745 . . . . 0.0 112.802 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -64.28 -33.94 76.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -69.95 -46.63 64.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.691 1.132 . . . . 0.0 112.022 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.42 -45.18 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.415 0.686 . . . . 0.0 109.709 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -67.58 -40.23 84.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.582 1.153 . . . . 0.0 111.712 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -63.39 -35.09 79.25 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.761 -1.212 . . . . 0.0 113.15 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.57 -19.54 41.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.75 -49.31 39.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.789 1.177 . . . . 0.0 112.028 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -67.89 -23.33 65.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.632 0.773 . . . . 0.0 112.066 -169.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.4 ptt-85 -100.01 -10.17 21.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.446 HD11 ' NE ' ' A' ' 65' ' ' ARG . 37.9 mt -59.0 167.5 1.62 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.225 0.921 . . . . 0.0 112.52 159.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -116.62 163.55 15.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.187 1.395 . . . . 0.0 110.949 160.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.59 76.07 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.518 2.008 . . . . 0.0 117.064 174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.74 136.42 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.628 1.971 . . . . 0.0 111.065 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.33 -4.75 4.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.5 138.68 1.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.465 1.506 . . . . 0.0 109.684 173.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.65 147.93 8.9 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.435 1.094 . . . . 0.0 113.093 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 m -153.75 150.87 28.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.795 1.638 . . . . 0.0 111.908 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.12 131.82 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.733 1.613 . . . . 0.0 110.642 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 m -107.97 91.52 3.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.235 1.414 . . . . 0.0 108.872 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.18 -30.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.721 1.609 . . . . 0.0 113.145 -167.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -38.11 36.51 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.718 1.607 . . . . 0.0 115.029 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 p -126.36 -8.19 6.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.562 1.945 . . . . 0.0 112.814 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.95 8.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.568 1.08 . . . . 0.0 112.052 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -99.32 170.56 8.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.531 1.165 . . . . 0.0 110.986 171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mt -136.58 154.85 50.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.286 1.435 . . . . 0.0 112.198 -171.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 m -137.66 132.03 32.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.42 2.288 . . . . 0.0 107.102 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.09 141.07 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.758 0.823 . . . . 0.0 111.412 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -134.42 117.04 15.86 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.317 1.847 . . . . 0.0 108.942 -175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -144.85 162.72 36.12 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.086 1.355 . . . . 0.0 112.583 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -91.65 119.37 68.52 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.114 1.366 . . . . 0.0 112.031 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -58.16 1.46 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.819 1 C-N-CA 125.486 4.124 . . . . 0.0 117.313 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -121.32 -25.0 5.31 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.022 1.283 . . . . 0.0 113.07 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -67.09 -45.98 75.63 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 156.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -156.3 -170.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.723 0.809 . . . . 0.0 111.838 -161.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 t -159.98 -154.36 0.39 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.853 1.261 . . . . 0.0 108.763 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.74 -32.33 5.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.883 1.673 . . . . 0.0 113.513 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mm -45.26 -34.96 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.332 1.453 . . . . 0.0 113.438 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.5 m -51.34 -23.19 3.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.954 2.502 . . . . 0.0 114.148 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.255 3.9 tt -139.23 -16.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.051 1.501 . . . . 0.0 115.051 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.2 -59.61 4.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.058 1.343 . . . . 0.0 110.773 168.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -69.41 -34.5 74.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.714 0.688 . . . . 0.0 112.038 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' NE ' HD11 ' A' ' 33' ' ' LEU . 44.2 mtm180 -67.87 -28.56 67.64 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -84.66 -52.52 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.016 0.825 . . . . 0.0 109.14 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.26 82.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.887 0.875 . . . . 0.0 112.689 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.14 -27.3 35.53 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 mt -86.53 -7.04 58.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.57 22.13 1.35 Allowed Glycine 0 N--CA 1.477 1.379 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.44 -177.84 5.03 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.02 1.328 . . . . 0.0 112.495 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.0 p -148.24 130.22 15.32 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.099 1.36 . . . . 0.0 111.992 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.7 pt? -92.36 160.79 14.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -167.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.72 94.57 2.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.563 1.545 . . . . 0.0 111.973 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.57 71.37 58.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.289 1.435 . . . . 0.0 109.495 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.512 3.475 . . . . 0.0 114.064 -173.042 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 CA--C 1.534 0.522 0 N-CA-C 112.697 0.23 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.59 138.31 44.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.238 1.018 . . . . 0.0 111.573 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -150.13 154.19 37.65 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.075 1.75 . . . . 0.0 110.196 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -103.91 153.64 20.56 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.812 1.245 . . . . 0.0 111.238 -168.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.86 149.53 16.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.32 1.448 . . . . 0.0 110.624 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -117.5 140.4 49.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.517 1.527 . . . . 0.0 110.806 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.04 156.44 47.37 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.025 1.73 . . . . 0.0 111.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.88 127.06 41.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.923 1.289 . . . . 0.0 108.957 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.461 1.104 . . . . 0.0 109.921 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.65 112.87 3.91 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 124.82 1.2 . . . . 0.0 111.297 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.6 -8.92 71.5 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 117.009 -1.995 . . . . 0.0 116.945 166.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -66.89 -15.37 63.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.661 2.73 . . . . 0.0 114.543 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -62.74 15.07 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.7 t -80.42 139.99 36.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.375 -1.453 . . . . 0.0 109.855 163.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.66 -4.17 2.81 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.89 5.24 12.17 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.854 1.662 . . . . 0.0 113.969 173.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.1 m -115.11 -43.25 3.1 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.43 -32.86 41.33 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.917 1.235 . . . . 0.0 110.633 161.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -60.11 -28.06 67.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.772 1.629 . . . . 0.0 113.276 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -71.27 -36.61 71.78 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.811 -1.181 . . . . 0.0 110.819 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mm -75.64 -39.08 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.453 1.501 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.62 -48.22 41.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.96 0.904 . . . . 0.0 110.604 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.43 -34.17 76.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.779 1.172 . . . . 0.0 112.905 178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.46 68.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -43.33 -53.66 5.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.536 1.135 . . . . 0.0 112.855 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -72.77 -14.74 61.6 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.912 0.387 . . . . 0.0 111.353 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -92.66 -15.54 26.66 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.67 178.89 0.92 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 0.0 111.618 158.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -141.14 137.91 33.08 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.47 21.78 25.98 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.311 1.91 . . . . 0.0 115.697 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.71 145.62 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.658 1.729 . . . . 0.0 110.578 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.46 -39.99 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -158.41 155.31 28.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.937 1.699 . . . . 0.0 109.461 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.68 126.44 5.07 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 162.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -131.52 119.92 22.21 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.745 1.218 . . . . 0.0 111.738 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.43 150.01 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 m -130.87 99.34 4.89 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.061 1.344 . . . . 0.0 109.196 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 -32.82 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.931 1.293 . . . . 0.0 111.769 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.7 -8.94 23.53 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.7 p -130.12 -23.64 2.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.844 1.258 . . . . 0.0 112.887 177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.19 48.05 21.05 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -135.66 161.83 34.45 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.721 1.208 . . . . 0.0 110.09 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.58 142.09 32.1 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.081 0.952 . . . . 0.0 109.197 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.0 m -115.33 125.7 53.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.312 1.445 . . . . 0.0 107.355 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.2 147.7 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.733 1.213 . . . . 0.0 109.905 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -127.92 134.35 49.33 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.718 1.207 . . . . 0.0 109.204 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -167.93 158.41 10.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.152 1.381 . . . . 0.0 113.074 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.36 128.1 60.87 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.112 1.365 . . . . 0.0 110.981 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.99 15.4 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.894 3.729 . . . . 0.0 114.412 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -128.08 -24.8 3.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.377 1.471 . . . . 0.0 112.71 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -72.82 -46.26 54.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.551 0.614 . . . . 0.0 110.706 161.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.08 176.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.15 0.98 . . . . 0.0 110.821 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.0 p -147.22 -162.13 1.48 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.617 0.767 . . . . 0.0 112.038 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -48.87 -29.12 4.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.948 0.899 . . . . 0.0 112.346 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.5 mm -53.36 -36.32 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 125.565 1.546 . . . . 0.0 113.048 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -11.93 29.82 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.114 1.766 . . . . 0.0 113.649 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tt -131.47 -25.98 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -55.59 -68.91 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.773 1.629 . . . . 0.0 111.25 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.43 -29.75 70.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.246 0.93 . . . . 0.0 111.681 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -75.0 -11.65 60.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.747 1.619 . . . . 0.0 113.842 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.49 -41.7 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.218 1.007 . . . . 0.0 110.071 172.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.28 -54.41 33.64 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.192 0.997 . . . . 0.0 112.427 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.15 -20.8 51.3 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.98 -20.37 63.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.123 0.969 . . . . 0.0 112.382 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.86 7.77 4.05 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -130.13 -165.21 1.51 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.579 1.19 . . . . 0.0 112.82 -166.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -144.6 166.99 23.59 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 111.059 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -147.38 161.84 40.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.53 122.9 9.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.697 . . . . 0.0 110.972 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -107.66 131.06 22.0 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--O 1.251 1.126 0 C-N-CA 122.268 1.978 . . . . 0.0 115.646 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 CA--C 1.537 0.647 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.04 -144.48 0.14 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.661 1.584 . . . . 0.0 111.91 -170.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -132.32 154.39 49.78 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.932 1.293 . . . . 0.0 112.698 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -136.61 148.91 47.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.802 1.641 . . . . 0.0 110.103 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -161.58 146.26 13.21 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.885 -0.509 . . . . 0.0 109.785 -163.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -113.56 158.09 21.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.762 1.225 . . . . 0.0 110.311 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.5 153.44 19.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 112.886 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -78.88 176.63 9.42 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.18 0.991 . . . . 0.0 111.154 163.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.29 153.94 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.035 1.734 . . . . 0.0 109.157 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.4 94.12 0.92 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.155 1.359 . . . . 0.0 111.973 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.4 -17.39 10.42 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.64 1.591 . . . . 0.0 115.805 165.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.29 127.3 33.54 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.351 1.576 . . . . 0.0 110.844 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -148.56 -22.23 0.32 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.119 1.768 . . . . 0.0 115.137 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 p -104.82 162.72 13.07 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.439 1.472 . . . . 0.0 114.484 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.39 86.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.737 1.615 . . . . 0.0 112.744 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.24 74.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.156 0.582 . . . . 0.0 111.461 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.2 m -68.63 -40.89 80.1 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.12 -33.82 63.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.221 0.464 . . . . 0.0 111.57 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -77.16 -35.16 56.24 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.612 -0.68 . . . . 0.0 111.466 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -64.31 -25.64 68.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 112.812 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.75 -60.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.401 1.081 . . . . 0.0 111.274 162.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -64.88 -30.84 71.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -165.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -66.68 -33.65 76.11 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.821 0.848 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.83 -34.25 19.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.662 0.785 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.67 -11.71 58.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.448 1.099 . . . . 0.0 113.961 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -87.37 -11.75 48.39 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 166.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -103.03 -26.11 13.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.949 1.299 . . . . 0.0 114.2 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -54.82 157.98 2.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 0.0 111.928 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -75.51 150.9 38.07 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.297 1.039 . . . . 0.0 112.301 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.29 13.78 60.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 116.87 1.508 . . . . 0.0 116.87 166.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.57 129.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.288 1.544 . . . . 0.0 110.096 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.29 -59.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.242 1.017 . . . . 0.0 112.006 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -150.46 128.46 11.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.737 1.215 . . . . 0.0 111.324 -171.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.41 162.08 41.57 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.7 p -165.46 133.12 3.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.334 1.053 . . . . 0.0 113.559 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.48 126.65 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.569 1.148 . . . . 0.0 108.286 165.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.0 m -90.97 93.85 9.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.0 -25.03 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.276 -169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.01 -27.56 32.53 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -137.45 -3.62 1.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.05 -5.86 69.58 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.703 1.62 . . . . 0.0 114.507 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.12 153.76 42.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.204 1.502 . . . . 0.0 111.163 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mt -111.29 157.14 20.49 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.571 1.548 . . . . 0.0 112.741 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -138.14 131.55 30.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.471 2.709 . . . . 0.0 105.497 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.3 134.92 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 m -114.85 122.92 47.82 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.076 2.151 . . . . 0.0 107.757 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.8 153.97 42.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.095 1.358 . . . . 0.0 111.77 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.73 111.23 42.96 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.227 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.01 11.85 0.67 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.59 3.526 . . . . 0.0 113.668 -173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -113.92 -45.6 3.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.304 1.442 . . . . 0.0 108.445 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -66.75 -39.1 87.79 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.055 1.342 . . . . 0.0 112.793 170.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 m -152.75 -168.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 125.137 1.375 . . . . 0.0 111.019 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.1 t -147.1 -179.7 7.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.089 1.356 . . . . 0.0 110.965 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.4 -29.68 1.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 114.187 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -40.95 -49.35 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.394 1.878 . . . . 0.0 113.112 166.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -63.91 -40.9 97.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.453 1.101 . . . . 0.0 112.138 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.64 -32.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.405 0.548 . . . . 0.0 111.569 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.67 -41.31 90.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.898 0.772 . . . . 0.0 111.799 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.27 -30.11 70.89 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.006 0.821 . . . . 0.0 113.182 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -77.99 -35.57 49.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.208 1.367 . . . . 0.0 112.297 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.02 -43.23 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.284 1.402 . . . . 0.0 111.007 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.38 80.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.32 -21.09 62.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.21 -15.79 62.48 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 163.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.46 63.16 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.172 1.368 . . . . 0.0 113.815 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -94.54 -167.06 1.58 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.584 1.192 . . . . 0.0 111.231 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.0 m -147.8 143.24 27.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 108.808 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -92.86 154.16 18.39 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.361 1.064 . . . . 0.0 112.315 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.03 43.6 2.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.505 1.122 . . . . 0.0 113.008 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.88 116.1 57.26 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 161.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.253 1.256 0 C-N-CA 121.914 1.743 . . . . 0.0 115.636 -159.677 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.537 0.641 0 N-CA-C 112.406 0.118 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -66.28 149.07 50.91 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.707 0.803 . . . . 0.0 112.305 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.73 146.55 23.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.742 1.217 . . . . 0.0 112.328 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 t -88.07 165.14 15.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.354 1.462 . . . . 0.0 113.033 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.77 158.23 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.466 2.306 . . . . 0.0 110.043 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.92 165.59 13.15 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.563 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.8 ptp -154.94 148.75 25.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.004 1.321 . . . . 0.0 112.236 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -89.41 142.48 27.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.375 1.07 . . . . 0.0 109.382 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 140.61 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.4 1.48 . . . . 0.0 110.609 -170.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.3 115.74 4.02 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 112.461 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.63 49.67 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.604 1.573 . . . . 0.0 115.198 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.1 ttp -118.0 3.57 12.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.659 1.73 . . . . 0.0 114.369 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.98 55.77 0.19 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.804 1.642 . . . . 0.0 113.677 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.4 t -153.52 130.26 10.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.168 2.187 . . . . 0.0 110.054 -175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.24 71.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.917 1.287 . . . . 0.0 113.095 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.79 91.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.611 0.765 . . . . 0.0 111.807 172.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.1 m -75.59 -42.27 52.4 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.327 1.051 . . . . 0.0 112.582 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.23 -35.74 60.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.13 0.572 . . . . 0.0 111.525 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -72.65 -23.26 60.88 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.754 -0.591 . . . . 0.0 112.254 -177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -81.88 -43.75 17.76 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.527 1.531 . . . . 0.0 111.496 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.29 -51.35 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 118.499 -0.762 . . . . 0.0 110.168 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -69.38 -28.11 65.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.85 1.204 . . . . 0.0 112.906 -169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.99 -34.65 71.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.469 1.031 . . . . 0.0 112.115 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.11 -35.53 36.68 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.392 -0.818 . . . . 0.0 112.761 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 tp -69.87 -16.19 63.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.558 1.143 . . . . 0.0 113.654 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -83.92 -7.0 59.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.623 1.169 . . . . 0.0 113.36 167.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -104.8 -40.87 5.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.133 1.373 . . . . 0.0 111.684 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -47.71 136.62 10.33 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.583 1.083 . . . . 0.0 111.47 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -66.03 164.65 14.9 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.06 -35.15 0.76 Allowed Glycine 0 N--CA 1.477 1.42 0 O-C-N 120.545 -1.347 . . . . 0.0 115.622 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.41 138.77 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.4 1.88 . . . . 0.0 110.497 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.4 -26.35 4.63 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -161.83 138.24 8.06 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.381 1.072 . . . . 0.0 110.705 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 163.56 39.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -160.22 122.93 3.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.049 0.939 . . . . 0.0 113.317 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -90.14 124.27 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.923 1.289 . . . . 0.0 109.653 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.2 m -94.42 100.99 12.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 108.625 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.89 -30.9 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -161.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.78 -39.94 62.75 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -125.93 -1.35 7.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.685 1.594 . . . . 0.0 113.456 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.68 5.07 86.01 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.936 1.731 . . . . 0.0 114.097 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -75.95 160.57 29.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.486 1.514 . . . . 0.0 111.985 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.34 156.19 42.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.502 1.121 . . . . 0.0 112.942 -168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 m -136.82 136.56 38.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.668 2.787 . . . . 0.0 105.65 169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.85 141.96 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 111.456 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -118.77 125.76 50.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.078 2.551 . . . . 0.0 108.527 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -152.26 162.87 40.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.532 1.133 . . . . 0.0 113.484 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.99 120.75 69.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.379 1.472 . . . . 0.0 111.06 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.75 8.29 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.485 3.457 . . . . 0.0 114.433 -171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -118.7 -40.89 2.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.47 1.108 . . . . 0.0 111.341 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -66.85 -36.13 81.63 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 117.499 -1.239 . . . . 0.0 111.747 165.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -151.91 179.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.837 1.198 . . . . 0.0 111.59 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.4 p -143.62 -172.57 3.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.168 1.387 . . . . 0.0 110.949 165.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.69 -33.12 2.77 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.135 1.374 . . . . 0.0 114.224 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mm -41.91 -45.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.963 1.705 . . . . 0.0 112.648 170.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -63.82 -38.87 92.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.92 0.888 . . . . 0.0 112.395 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.6 -31.03 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 118.696 0.68 . . . . 0.0 111.814 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.42 -53.05 61.12 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.044 0.938 . . . . 0.0 110.974 172.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.64 -19.43 64.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.278 1.031 . . . . 0.0 113.22 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -83.59 -49.21 9.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.914 1.286 . . . . 0.0 111.058 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.0 mt -63.87 -44.29 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.251 0.932 . . . . 0.0 111.116 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.97 84.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.904 0.882 . . . . 0.0 113.042 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.17 -36.77 58.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.353 1.061 . . . . 0.0 112.385 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.68 -20.03 66.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.101 1.36 . . . . 0.0 111.767 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.38 5.3 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 125.119 1.342 . . . . 0.0 115.094 164.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.19 -169.01 1.53 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.124 1.37 . . . . 0.0 110.599 -172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -150.97 172.1 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.051 -1.656 . . . . 0.0 111.583 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.96 162.22 34.65 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.27 1.428 . . . . 0.0 114.036 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.54 106.56 6.31 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.485 1.514 . . . . 0.0 109.148 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.11 86.73 51.24 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 125.503 1.521 . . . . 0.0 107.835 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.865 3.71 . . . . 0.0 115.731 -160.513 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 CA--C 1.534 0.477 0 N-CA-C 114.207 0.81 . . . . 0.0 114.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.462 ' CD2' ' H ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -75.72 149.28 38.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.622 1.969 . . . . 0.0 115.05 -175.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 130.83 53.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.761 1.624 . . . . 0.0 112.941 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.4 m -81.72 140.79 34.1 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.544 1.538 . . . . 0.0 109.268 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -163.88 149.66 11.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.744 0.702 . . . . 0.0 112.557 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -86.46 142.95 28.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 111.028 170.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.8 ttm -134.5 126.01 28.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.978 2.111 . . . . 0.0 109.706 -171.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -78.43 135.84 37.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.809 0.844 . . . . 0.0 109.479 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.78 141.18 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.48 1.512 . . . . 0.0 109.719 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.11 134.69 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.047 1.308 . . . . 0.0 112.306 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.14 -19.84 52.72 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.71 1.624 . . . . 0.0 115.399 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.2 ttp -73.32 -19.24 61.08 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.681 1.241 . . . . 0.0 112.552 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -67.89 91.82 0.34 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.437 2.295 . . . . 0.0 110.196 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t 175.92 149.8 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.708 2.803 . . . . 0.0 109.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 122.1 10.71 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.1 -6.56 1.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.634 2.774 . . . . 0.0 114.605 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.36 -23.01 66.27 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -162.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.88 68.11 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -70.65 -17.43 62.86 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.562 -1.336 . . . . 0.0 112.673 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -79.46 -15.05 58.45 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.386 1.874 . . . . 0.0 112.206 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.35 -49.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.874 1.27 . . . . 0.0 110.028 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -74.32 -28.36 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.232 -0.889 . . . . 0.0 113.265 -164.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.926 1.239 . . . . 0.0 111.443 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -29.71 62.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.83 1.252 . . . . 0.0 112.917 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.0 tp -63.44 -19.87 65.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -169.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -81.03 -7.24 59.51 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.428 1.091 . . . . 0.0 113.759 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -120.91 -11.31 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 114.313 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -62.66 159.23 16.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.743 1.156 . . . . 0.0 112.746 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 57' ' ' VAL . 20.5 ptmt -82.2 138.14 34.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.286 1.434 . . . . 0.0 114.398 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.87 21.91 71.69 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.652 1.596 . . . . 0.0 115.651 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.62 117.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.957 1.703 . . . . 0.0 111.223 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.46 -27.0 10.69 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -162.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.7 107.85 1.34 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.941 0.792 . . . . 0.0 112.702 -167.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.96 165.09 30.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.248 1.019 . . . . 0.0 113.613 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -158.76 128.13 5.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.938 -1.102 . . . . 0.0 113.22 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 158.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.222 0.609 . . . . 0.0 112.026 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 m -129.07 107.48 9.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.376 1.071 . . . . 0.0 109.212 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.2 t -71.37 -39.13 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -168.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -37.91 69.78 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 p -119.59 -4.08 10.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.33 1.452 . . . . 0.0 113.746 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.42 43.85 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.392 0.996 . . . . 0.0 113.227 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.4 ptt85 -114.42 179.81 3.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.218 1.807 . . . . 0.0 112.118 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.57 158.06 44.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.396 1.078 . . . . 0.0 113.26 -169.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 86.4 m -135.07 136.4 41.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.443 2.297 . . . . 0.0 106.552 167.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.13 141.28 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.517 0.727 . . . . 0.0 112.134 -167.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -119.66 109.04 15.18 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 109.91 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -143.69 163.34 33.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.282 1.433 . . . . 0.0 112.526 -172.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.69 145.22 30.75 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 121.047 -1.033 . . . . 0.0 112.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -89.56 9.23 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.342 2.695 . . . . 0.0 113.52 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -127.57 -46.93 1.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -22.92 18.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.075 1.35 . . . . 0.0 111.369 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 34' ' ' LYS . 25.4 m -132.49 -157.9 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.761 1.224 . . . . 0.0 111.229 165.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -173.8 -170.14 0.55 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.731 2.812 . . . . 0.0 108.285 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -53.37 -18.94 2.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 120.991 -1.068 . . . . 0.0 113.493 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mm -53.31 -33.09 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.537 . . . . 0.0 113.325 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -54.58 -46.9 73.83 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.26 1.024 . . . . 0.0 111.62 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tt -99.04 -27.59 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.738 0.815 . . . . 0.0 111.802 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -54.69 -48.51 72.34 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.342 1.057 . . . . 0.0 111.403 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -68.69 -7.36 32.76 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -53.7 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.684 1.594 . . . . 0.0 110.398 163.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.65 -47.43 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.899 0.772 . . . . 0.0 111.322 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.87 -22.0 64.23 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.86 -20.96 30.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.168 1.387 . . . . 0.0 112.796 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.12 -6.96 49.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.89 0.876 . . . . 0.0 112.947 158.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.21 3.0 89.13 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.948 1.261 . . . . 0.0 113.664 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -86.04 -167.93 2.04 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.901 1.68 . . . . 0.0 110.258 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -156.83 174.42 15.53 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.503 -1.373 . . . . 0.0 110.927 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -143.83 173.24 11.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.822 1.649 . . . . 0.0 113.738 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.94 141.51 17.79 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.737 1.615 . . . . 0.0 111.76 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 77.53 5.4 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.409 . . . . 0.0 108.026 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.985 3.123 . . . . 0.0 115.306 -164.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 N--CA 1.472 0.256 0 CA-C-O 119.257 -0.393 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -84.0 133.54 34.67 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.516 0.598 . . . . 0.0 111.166 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -133.66 152.9 51.99 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.541 1.936 . . . . 0.0 111.785 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -78.66 159.59 27.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.114 0.966 . . . . 0.0 111.34 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -166.63 140.89 4.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.163 1.785 . . . . 0.0 109.08 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.33 143.28 28.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 0.0 111.391 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.52 152.22 50.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.521 1.928 . . . . 0.0 110.201 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.6 148.93 24.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.735 1.614 . . . . 0.0 109.573 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.03 127.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.979 1.312 . . . . 0.0 109.999 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.58 113.52 3.82 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 125.428 1.49 . . . . 0.0 110.575 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.12 -31.32 4.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.911 1.72 . . . . 0.0 112.63 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 32.6 ttp -81.6 114.93 20.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.056 0.928 . . . . 0.0 109.308 165.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 178.43 131.34 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.601 2.761 . . . . 0.0 109.087 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m 61.66 166.09 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.928 1.691 . . . . 0.0 113.101 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.8 -172.24 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.613 1.565 . . . . 0.0 114.085 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.35 -8.07 59.48 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -168.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -55.62 -31.4 62.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.97 -30.93 1.97 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.423 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m -61.6 -32.92 73.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.817 -1.177 . . . . 0.0 113.096 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 m -78.15 -10.37 59.6 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.141 -0.974 . . . . 0.0 112.476 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.22 -56.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 159.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.23 -45.3 80.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.896 0.878 . . . . 0.0 113.283 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -71.2 -31.95 68.23 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.582 0.628 . . . . 0.0 112.482 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.48 27.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.566 0.621 . . . . 0.0 111.951 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.13 -58.37 3.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.521 1.528 . . . . 0.0 112.889 -162.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.28 -9.55 53.7 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 mtp85 -108.38 -10.56 15.3 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.125 2.17 . . . . 0.0 113.403 -174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.08 -19.31 63.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 75.36 151.44 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.688 2.795 . . . . 0.0 113.507 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.44 -44.8 1.45 Allowed Glycine 0 N--CA 1.478 1.445 0 C-N-CA 126.634 2.064 . . . . 0.0 114.402 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.84 154.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.051 1.34 . . . . 0.0 109.803 156.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.59 -49.92 0.78 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -154.89 149.41 26.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.944 1.298 . . . . 0.0 109.865 -166.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.75 149.62 23.79 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -119.51 118.98 32.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.221 1.409 . . . . 0.0 111.161 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.54 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.691 1.196 . . . . 0.0 111.646 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.9 m -120.85 103.14 8.85 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.01 -35.51 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.878 0.871 . . . . 0.0 112.386 -171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.15 -52.88 36.07 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.474 1.034 . . . . 0.0 111.521 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -84.51 -7.82 59.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.919 1.688 . . . . 0.0 112.337 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.8 76.6 0.19 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.534 2.016 . . . . 0.0 113.455 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -151.52 171.45 17.56 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.029 1.331 . . . . 0.0 112.15 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 mt -132.2 152.94 51.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 112.623 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.1 m -124.1 134.74 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 161.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.4 140.32 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.944 0.898 . . . . 0.0 111.735 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.1 m -105.36 127.34 52.92 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.813 2.045 . . . . 0.0 109.687 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.04 158.38 37.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 113.259 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -93.0 117.23 67.46 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.653 1.181 . . . . 0.0 108.784 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.58 9.18 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.403 3.402 . . . . 0.0 113.633 -167.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -131.18 -20.5 2.71 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.825 0.85 . . . . 0.0 112.857 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -71.74 -41.57 68.32 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.919 0.887 . . . . 0.0 110.529 155.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -150.31 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.998 1.319 . . . . 0.0 111.176 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.7 p -172.37 -163.19 0.22 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.995 2.518 . . . . 0.0 109.007 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.92 -22.27 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 165.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.01 -48.49 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.919 1.287 . . . . 0.0 112.626 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.7 m -64.7 -37.15 86.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.355 0.662 . . . . 0.0 111.896 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 tt -85.92 -30.71 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.334 1.054 . . . . 0.0 112.225 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -53.87 -52.53 60.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.738 1.215 . . . . 0.0 110.582 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.9 -23.48 63.52 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -53.96 5.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.964 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.26 -39.25 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.839 -1.163 . . . . 0.0 112.132 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.79 73.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 0.0 112.666 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.08 -26.7 22.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.302 1.841 . . . . 0.0 113.964 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.88 -25.58 65.19 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.189 -0.944 . . . . 0.0 111.861 162.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.44 9.54 5.9 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.89 1.709 . . . . 0.0 113.962 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -104.97 -167.66 1.37 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.164 . . . . 0.0 111.741 -170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -139.25 168.73 19.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.357 2.263 . . . . 0.0 108.845 169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 164.95 30.91 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.12 146.07 23.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.446 1.098 . . . . 0.0 113.104 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.8 72.19 41.91 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.932 1.293 . . . . 0.0 109.957 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.255 1.34 0 C-N-CA 123.731 2.954 . . . . 0.0 112.072 -179.118 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo . . . . . 0 N--CA 1.48 0.732 0 N-CA-C 112.365 0.102 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -169.41 156.53 6.84 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.212 1.405 . . . . 0.0 111.464 -169.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -75.69 131.1 39.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.553 0.741 . . . . 0.0 112.629 -164.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -92.54 164.89 13.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 110.852 161.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -165.37 145.36 6.83 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.688 1.595 . . . . 0.0 110.309 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -82.64 138.58 34.12 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.324 1.449 . . . . 0.0 109.744 167.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.0 ttm -129.69 144.91 51.51 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.364 1.866 . . . . 0.0 109.399 -170.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.84 168.31 9.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.424 . . . . 0.0 109.653 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.2 145.81 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.423 1.089 . . . . 0.0 111.904 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.98 59.13 3.53 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.346 1.927 . . . . 0.0 115.512 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.13 27.1 4.66 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.99 1.281 . . . . 0.0 115.772 165.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttm -64.22 -14.06 53.03 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.517 1.658 . . . . 0.0 115.334 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -72.8 -7.64 51.67 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.954 1.706 . . . . 0.0 114.673 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -52.62 -23.64 6.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.84 -161.94 0.96 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.243 2.217 . . . . 0.0 109.443 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.64 11.99 0.42 Allowed 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.0 -25.6 44.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -163.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.17 -38.11 11.28 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.11 1.323 . . . . 0.0 111.984 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -67.12 -35.48 79.83 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.266 -0.896 . . . . 0.0 112.919 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 m -75.81 -11.04 59.91 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.714 -1.241 . . . . 0.0 113.034 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.5 mm -87.35 -55.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -59.84 -44.35 94.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 112.676 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.7 -21.98 63.45 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.589 1.156 . . . . 0.0 113.383 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.21 -40.11 9.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.665 1.186 . . . . 0.0 112.096 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.7 -27.12 68.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.781 1.632 . . . . 0.0 112.951 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.53 -12.28 61.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.713 1.205 . . . . 0.0 113.277 170.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -113.79 -34.68 5.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.149 1.379 . . . . 0.0 113.879 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.9 mt -44.03 135.96 3.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.26 1.424 . . . . 0.0 112.88 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.41 159.79 33.4 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.71 -41.16 2.52 Favored Glycine 0 N--CA 1.475 1.289 0 C-N-CA 125.718 1.627 . . . . 0.0 114.979 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.5 133.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.216 1.406 . . . . 0.0 110.942 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.24 -9.92 14.98 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -168.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -178.18 136.49 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.943 2.097 . . . . 0.0 108.578 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.99 155.78 8.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.2 t -162.22 137.01 6.93 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.132 -0.98 . . . . 0.0 112.032 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -77.76 161.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 118.652 0.66 . . . . 0.0 111.478 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -136.63 76.12 1.58 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.089 1.356 . . . . 0.0 108.559 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.99 -33.89 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.703 1.201 . . . . 0.0 111.352 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.35 -22.34 61.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 p -129.24 -2.65 5.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.098 1.359 . . . . 0.0 113.186 171.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.75 38.42 23.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.264 -1.298 . . . . 0.0 112.937 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -122.31 -178.73 3.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.522 1.529 . . . . 0.0 111.933 -176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.91 163.77 29.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.386 2.274 . . . . 0.0 110.677 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -135.23 138.1 43.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.811 1.644 . . . . 0.0 106.886 163.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.18 137.88 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.437 0.695 . . . . 0.0 112.277 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -110.45 118.93 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.758 2.023 . . . . 0.0 110.52 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -147.23 155.97 42.55 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.996 0.919 . . . . 0.0 113.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.86 117.87 66.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.575 1.15 . . . . 0.0 108.611 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.02 11.75 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.436 3.424 . . . . 0.0 113.563 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.36 -31.46 2.06 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.454 1.102 . . . . 0.0 112.744 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -70.54 -40.31 73.49 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.036 0.835 . . . . 0.0 111.254 163.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.34 -161.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.736 1.615 . . . . 0.0 109.477 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.2 p -160.96 -165.23 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.591 1.556 . . . . 0.0 109.48 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.89 -29.17 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.212 1.005 . . . . 0.0 113.33 161.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.55 -48.17 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.049 1.34 . . . . 0.0 112.395 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.8 m -53.92 -32.3 53.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.134 0.973 . . . . 0.0 112.622 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -104.43 -26.25 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.883 1.273 . . . . 0.0 113.325 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.51 -47.44 73.07 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.488 1.115 . . . . 0.0 110.228 161.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -49.5 -34.02 16.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.193 1.797 . . . . 0.0 113.644 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -92.91 -46.4 7.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.038 1.335 . . . . 0.0 112.065 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.35 -39.25 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.239 -0.913 . . . . 0.0 111.642 -175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.86 61.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.31 -38.22 42.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.306 1.043 . . . . 0.0 111.574 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.41 -12.71 60.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.53 -2.66 46.12 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.221 1.391 . . . . 0.0 114.895 171.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.58 -167.56 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 118.464 1.132 . . . . 0.0 111.22 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -153.56 130.7 11.12 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.286 -1.509 . . . . 0.0 109.213 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.46 168.13 20.26 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.77 142.09 34.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.569 1.548 . . . . 0.0 111.039 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -154.07 103.96 2.45 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.152 0.981 . . . . 0.0 108.837 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 C--O 1.254 1.277 0 C-N-CA 124.274 3.316 . . . . 0.0 114.543 -163.148 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.472 0.214 0 CA-C-O 119.494 -0.294 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.95 135.22 56.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.6 0.76 . . . . 0.0 111.89 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -101.35 142.16 33.16 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.066 1.347 . . . . 0.0 111.185 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 m -100.12 152.35 20.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.995 1.318 . . . . 0.0 108.462 167.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -148.35 153.12 38.18 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.75 0.82 . . . . 0.0 109.039 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -125.95 135.64 52.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.904 1.682 . . . . 0.0 108.74 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -135.33 147.87 49.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.687 0.795 . . . . 0.0 111.442 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -101.51 121.73 42.5 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.2 129.18 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.264 1.025 . . . . 0.0 110.222 -156.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.29 123.9 7.46 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.112 1.339 . . . . 0.0 113.178 -167.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.81 -9.48 77.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.32 1.914 . . . . 0.0 115.482 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.0 ttp -88.35 3.09 51.04 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.076 1.438 . . . . 0.0 114.518 -167.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -54.49 138.52 40.19 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.451 1.1 . . . . 0.0 111.651 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.9 m 90.11 149.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 129.25 3.02 . . . . 0.0 113.31 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.16 84.07 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -160.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.59 66.91 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.302 -0.874 . . . . 0.0 112.801 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.5 m -92.21 -46.02 7.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.701 1.6 . . . . 0.0 111.975 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.13 17.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.854 0.861 . . . . 0.0 112.03 165.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -68.88 -27.69 66.03 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 m -67.34 -28.05 67.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 111.651 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.24 -55.79 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.377 1.071 . . . . 0.0 110.066 165.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -69.58 -40.21 76.84 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.455 0.702 . . . . 0.0 112.299 -158.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -63.41 -30.3 71.45 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.309 0.504 . . . . 0.0 112.126 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.75 -28.53 21.67 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.054 1.342 . . . . 0.0 113.905 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.85 -45.42 90.14 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.632 1.106 . . . . 0.0 112.174 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.47 -4.4 33.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -102.03 -16.97 16.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.42 1.488 . . . . 0.0 113.062 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.36 121.25 11.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.716 1.144 . . . . 0.0 111.252 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.6 115.73 6.1 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.496 -0.752 . . . . 0.0 110.966 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.26 -23.92 9.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.548 1.547 . . . . 0.0 113.707 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.87 139.08 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.538 1.169 . . . . 0.0 109.746 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.71 -39.69 4.24 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -168.78 125.98 1.0 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.74 1.155 . . . . 0.0 111.987 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.22 170.13 16.56 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -167.25 136.08 2.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.304 1.042 . . . . 0.0 112.591 170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.43 129.89 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 166.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.7 m -86.97 102.71 14.64 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.9 t -68.72 -31.53 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -157.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.48 -13.21 58.33 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -127.96 -25.84 2.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.985 1.314 . . . . 0.0 112.9 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.56 75.87 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.682 1.134 . . . . 0.0 113.276 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -75.29 156.87 35.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.365 1.082 . . . . 0.0 111.546 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -120.18 159.28 25.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.072 0.949 . . . . 0.0 113.269 -170.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 m -141.03 134.9 30.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.933 2.093 . . . . 0.0 106.755 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.27 129.24 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.874 0.869 . . . . 0.0 111.278 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.3 m -99.09 134.04 42.51 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.721 2.008 . . . . 0.0 107.83 167.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.06 161.03 41.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.029 1.332 . . . . 0.0 113.027 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.68 111.21 24.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.03 15.73 0.91 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.151 3.234 . . . . 0.0 113.663 -171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -123.27 -34.88 3.05 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.839 1.255 . . . . 0.0 110.535 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -67.69 -45.77 74.21 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.205 164.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.64 179.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 119.663 1.12 . . . . 0.0 112.429 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 p -149.88 -167.76 2.91 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.809 1.244 . . . . 0.0 111.823 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -25.51 0.8 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.632 1.573 . . . . 0.0 114.665 170.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -51.46 -46.22 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.287 1.435 . . . . 0.0 112.662 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -68.4 -33.09 73.62 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.496 1.118 . . . . 0.0 112.515 -171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.6 tt -85.17 -29.71 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.745 0.702 . . . . 0.0 112.31 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -55.79 -52.94 62.24 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.753 1.221 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.17 -41.95 96.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.853 -174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -62.98 -37.2 86.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.219 1.408 . . . . 0.0 112.437 173.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -65.45 -48.74 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.327 1.422 . . . . 0.0 110.822 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.07 -34.88 79.08 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.67 63.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.4 1.48 . . . . 0.0 113.66 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.5 9.43 31.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.755 1.222 . . . . 0.0 112.64 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 35.0 21.18 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 123.833 0.73 . . . . 0.0 112.686 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -121.48 179.8 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.274 1.43 . . . . 0.0 110.474 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -145.98 171.36 14.97 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.992 1.317 . . . . 0.0 109.686 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.18 159.19 43.64 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.37 120.36 30.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.464 1.906 . . . . 0.0 109.543 159.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -119.7 136.54 24.84 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.325 1.85 . . . . 0.0 106.944 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--O 1.255 1.358 0 C-N-CA 122.154 1.903 . . . . 0.0 116.656 -152.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.436 0.514 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -56.77 142.59 40.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.324 1.05 . . . . 0.0 113.136 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -158.46 149.87 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.502 1.921 . . . . 0.0 110.077 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -67.65 154.19 42.02 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.854 0.835 . . . . 0.0 110.871 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -156.97 136.88 12.52 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.339 1.855 . . . . 0.0 108.12 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -116.28 147.29 41.67 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.831 1.252 . . . . 0.0 109.52 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.31 161.58 42.18 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.272 1.029 . . . . 0.0 112.285 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.99 158.52 18.0 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.336 165.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.9 147.85 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.244 2.218 . . . . 0.0 109.706 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.39 33.44 0.44 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.5 2.0 . . . . 0.0 116.59 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 56.53 1.87 Allowed Glycine 0 N--CA 1.466 0.679 0 C-N-CA 125.017 1.294 . . . . 0.0 113.854 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -9.06 50.52 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.1 mtp85 -60.31 140.53 57.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.016 1.326 . . . . 0.0 112.62 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m 75.23 8.02 4.02 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.16 2.584 . . . . 0.0 114.327 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.02 16.25 10.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.732 1.613 . . . . 0.0 114.421 -174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.93 -7.84 0.59 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.627 2.371 . . . . 0.0 114.776 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.21 -22.79 67.1 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.443 -1.411 . . . . 0.0 114.575 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.71 65.47 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.575 1.08 . . . . 0.0 112.782 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -89.32 -36.6 15.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.398 0.999 . . . . 0.0 111.402 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -64.98 -27.81 69.09 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.494 -1.379 . . . . 0.0 113.399 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.09 -59.57 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.776 0.83 . . . . 0.0 109.742 162.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.69 -31.61 71.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -162.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -58.93 -33.63 70.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.991 0.916 . . . . 0.0 112.429 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.96 -39.29 15.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.132 0.973 . . . . 0.0 112.128 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.65 -28.47 69.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -70.9 -13.69 62.11 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.214 0.916 . . . . 0.0 113.315 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -129.46 -6.74 4.71 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -168.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.29 132.98 44.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.064 1.302 . . . . 0.0 111.1 168.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -59.92 129.1 40.16 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.819 -0.551 . . . . 0.0 110.765 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.68 -2.56 86.1 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.234 1.397 . . . . 0.0 115.199 -173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.69 136.89 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.149 1.475 . . . . 0.0 109.239 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.33 -50.06 3.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.942 1.297 . . . . 0.0 113.914 -172.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -154.14 144.89 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 111.308 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.26 157.93 20.87 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -155.31 138.71 15.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.987 0.915 . . . . 0.0 112.183 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.72 124.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.239 1.016 . . . . 0.0 109.428 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.2 m -81.82 109.44 16.21 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.583 1.153 . . . . 0.0 108.617 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.82 -40.6 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.715 0.806 . . . . 0.0 112.595 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.86 81.77 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 p -95.27 -11.84 27.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.221 1.408 . . . . 0.0 113.241 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.64 63.94 2.88 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.841 1.21 . . . . 0.0 112.708 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -154.51 171.2 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.885 1.674 . . . . 0.0 111.389 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.6 152.18 40.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.5 m -133.67 128.52 35.21 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.751 2.42 . . . . 0.0 107.139 167.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.21 139.72 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.684 1.194 . . . . 0.0 110.318 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.7 m -112.57 105.03 13.14 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.442 1.497 . . . . 0.0 108.11 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -130.97 158.33 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.759 1.224 . . . . 0.0 112.53 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -91.98 113.24 58.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.95 1.7 . . . . 0.0 110.552 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.91 -7.72 3.77 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 124.525 3.484 . . . . 0.0 115.554 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -104.51 -37.22 7.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.671 1.189 . . . . 0.0 110.624 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.26 -36.7 66.42 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.194 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.63 175.47 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 120.733 1.606 . . . . 0.0 113.572 -168.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.2 p -135.2 -168.26 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.487 1.115 . . . . 0.0 111.862 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.23 -22.56 0.68 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.4 1.08 . . . . 0.0 113.483 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -52.79 -48.8 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.088 1.355 . . . . 0.0 111.967 172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 m -60.01 -34.68 73.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.739 0.816 . . . . 0.0 112.276 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -92.82 -25.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.075 0.95 . . . . 0.0 112.521 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -58.95 -45.54 90.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.946 1.248 . . . . 0.0 110.342 166.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.31 7.64 0.13 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.013 1.725 . . . . 0.0 114.402 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -121.69 -46.91 2.22 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 0.0 111.381 165.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -67.87 -45.57 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 120.568 -1.332 . . . . 0.0 112.183 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.47 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.3 0.5 . . . . 0.0 111.601 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.67 62.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.395 1.478 . . . . 0.0 113.156 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 69' ' ' LEU . 2.5 mm? -76.77 -10.67 59.54 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.109 0.868 . . . . 0.0 112.709 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.12 3.71 12.94 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 165.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -107.09 -153.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.905 1.352 . . . . 0.0 112.516 -172.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 p -139.62 -172.47 3.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.169 1.788 . . . . 0.0 108.659 160.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 172.94 12.12 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.974 1.309 . . . . 0.0 112.64 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.41 105.5 4.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.474 1.109 . . . . 0.0 111.812 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -117.52 71.23 6.86 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 127.04 2.136 . . . . 0.0 110.63 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 C--O 1.256 1.393 0 C-N-CA 123.973 3.115 . . . . 0.0 114.234 -174.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 N-CA-C 113.265 0.448 . . . . 0.0 113.265 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -70.15 152.32 44.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.146 0.578 . . . . 0.0 112.145 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -160.18 151.32 19.26 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.891 0.876 . . . . 0.0 112.627 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -70.3 151.85 44.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.918 0.887 . . . . 0.0 111.434 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -155.66 137.63 14.52 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.255 2.222 . . . . 0.0 107.025 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -107.51 146.25 32.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.763 0.825 . . . . 0.0 110.031 170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.2 ptp -131.9 164.54 25.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.927 2.091 . . . . 0.0 110.268 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -97.79 178.75 5.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.964 0.905 . . . . 0.0 109.345 164.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 p -164.64 129.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.616 1.167 . . . . 0.0 110.944 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.42 136.71 14.35 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 125.408 1.48 . . . . 0.0 110.068 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.84 -47.4 3.55 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.137 -1.368 . . . . 0.0 113.918 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.7 ttp -67.88 110.96 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.946 1.873 . . . . 0.0 110.233 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -176.49 -14.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -78.11 165.05 24.45 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 173.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.28 144.9 44.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.389 0.676 . . . . 0.0 112.339 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.95 14.77 6.66 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.199 1.8 . . . . 0.0 114.702 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.5 m -84.55 -18.77 34.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -174.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.11 -28.74 69.31 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.694 1.134 . . . . 0.0 111.829 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.8 m -56.92 -36.59 70.36 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.365 1.066 . . . . 0.0 112.721 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -73.15 -12.62 60.95 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.704 1.202 . . . . 0.0 112.274 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.54 -48.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.239 1.415 . . . . 0.0 109.951 165.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.31 -26.65 64.83 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.545 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -77.9 -5.54 51.36 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.157 0.889 . . . . 0.0 112.895 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.56 -37.64 7.47 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.579 -1.326 . . . . 0.0 112.645 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.59 -33.08 71.01 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.18 -10.42 59.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -99.17 -25.57 14.48 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.514 1.526 . . . . 0.0 112.828 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.7 158.85 14.59 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.195 1.398 . . . . 0.0 111.984 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -89.33 149.61 22.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.197 0.999 . . . . 0.0 113.08 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 -1.02 85.69 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 117.009 1.564 . . . . 0.0 117.009 165.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -108.62 136.7 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.67 1.588 . . . . 0.0 110.769 -173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.34 -27.18 8.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -173.49 150.46 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 111.97 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.38 -177.27 6.42 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -169.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.6 m -172.27 129.74 0.59 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.63 2.372 . . . . 0.0 111.42 166.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.0 142.59 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.888 1.675 . . . . 0.0 109.718 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 m -122.82 87.7 2.8 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.544 1.138 . . . . 0.0 110.284 173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.8 -27.88 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.812 1.245 . . . . 0.0 112.241 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.61 53.38 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.0 p -130.64 -21.74 2.76 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.747 1.619 . . . . 0.0 113.246 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 62.0 1.7 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -140.28 162.54 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.577 1.551 . . . . 0.0 110.986 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.87 144.13 32.35 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.91 1.284 . . . . 0.0 109.036 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 m -127.38 133.69 50.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.922 1.289 . . . . 0.0 107.75 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.89 134.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.757 0.823 . . . . 0.0 112.053 -165.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -101.96 114.51 28.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.601 1.96 . . . . 0.0 108.205 172.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -135.98 164.63 27.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.254 1.021 . . . . 0.0 112.209 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.9 118.01 68.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.344 1.057 . . . . 0.0 109.237 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.09 8.34 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.809 3.006 . . . . 0.0 113.332 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -119.98 -32.14 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 111.114 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -68.9 -43.29 75.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.648 1.179 . . . . 0.0 110.997 162.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.07 -177.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -169.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.5 p -145.69 -162.23 1.47 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.083 2.153 . . . . 0.0 108.062 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -23.53 4.99 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 167.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm -53.09 -30.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.412 -1.43 . . . . 0.0 113.599 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 t -61.82 -27.5 68.81 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.532 1.06 . . . . 0.0 113.055 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tt -122.43 -17.84 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.566 1.146 . . . . 0.0 113.373 -171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -56.75 -49.67 74.57 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.07 2.148 . . . . 0.0 113.134 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.86 -35.89 72.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 110.833 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -62.31 -51.12 68.93 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.047 0.939 . . . . 0.0 110.824 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.32 -38.78 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.715 1.143 . . . . 0.0 110.96 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.83 -44.39 89.99 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.929 0.786 . . . . 0.0 112.799 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.85 -28.17 66.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.237 1.015 . . . . 0.0 113.459 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -68.54 -8.24 39.64 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 0.0 114.373 171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -2.47 61.2 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 113.843 -176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.77 -175.13 4.06 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.977 1.711 . . . . 0.0 111.013 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.8 p -154.35 120.4 5.3 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.765 1.226 . . . . 0.0 111.402 167.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.63 163.17 28.49 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.58 75.81 1.6 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.375 1.07 . . . . 0.0 111.048 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 100.1 32.88 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.908 1.683 . . . . 0.0 107.11 170.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.73 2.287 . . . . 0.0 115.21 -151.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.48 0.693 0 N-CA-C 113.1 0.384 . . . . 0.0 113.1 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.27 150.1 48.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.599 1.56 . . . . 0.0 110.725 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -150.73 149.18 29.46 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.6 m -88.15 151.11 22.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.583 1.953 . . . . 0.0 111.365 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -155.98 145.54 20.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.819 2.048 . . . . 0.0 106.65 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -104.79 157.01 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.033 0.533 . . . . 0.0 111.099 163.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ptp -141.2 148.68 40.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.518 0.727 . . . . 0.0 111.74 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -86.89 154.0 21.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.328 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -155.64 126.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.786 1.634 . . . . 0.0 109.927 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.04 70.59 2.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.212 0.91 . . . . 0.0 113.58 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.88 5.72 1.61 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 167.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.07 -21.67 65.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.584 1.692 . . . . 0.0 113.704 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -63.2 7.27 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.1 p -85.35 -155.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.521 1.929 . . . . 0.0 113.241 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -75.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.49 -10.77 19.08 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -164.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 t -60.62 -31.5 70.68 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.49 64.84 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.882 1.273 . . . . 0.0 112.439 168.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.1 m -78.15 -45.19 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.851 -1.155 . . . . 0.0 110.402 171.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 m -67.01 -22.4 65.9 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.291 1.436 . . . . 0.0 114.763 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.83 -64.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.16 0.584 . . . . 0.0 109.68 159.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.86 -31.23 63.07 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.509 -0.745 . . . . 0.0 112.026 -156.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -68.89 -27.29 65.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.328 0.651 . . . . 0.0 112.433 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.09 -30.31 16.81 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.394 1.078 . . . . 0.0 112.287 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.6 tp -73.9 1.01 11.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.278 1.431 . . . . 0.0 113.874 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -89.59 1.01 56.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 159.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -119.77 -56.04 2.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 111.401 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.62 145.36 33.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.815 0.846 . . . . 0.0 112.206 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HE2' ' CG ' ' A' ' 52' ' ' TYR . 63.0 tttt 72.09 143.1 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.665 2.386 . . . . 0.0 112.158 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.33 62.93 1.42 Allowed Glycine 0 N--CA 1.477 1.421 0 C-N-CA 125.143 1.354 . . . . 0.0 112.609 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -101.99 126.99 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.995 1.718 . . . . 0.0 111.54 -166.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.25 -24.3 20.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.557 1.143 . . . . 0.0 113.458 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -165.23 127.74 2.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 111.187 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.56 148.21 27.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 m -152.64 142.16 21.75 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.912 1.285 . . . . 0.0 111.72 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.1 m -110.07 132.94 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.019 1.727 . . . . 0.0 111.217 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.0 m -105.97 121.89 45.02 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.431 1.492 . . . . 0.0 107.972 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.84 -28.16 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.308 1.043 . . . . 0.0 112.167 -163.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -37.82 85.48 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -111.53 -17.15 13.13 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.792 2.037 . . . . 0.0 113.102 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.94 77.07 0.61 Allowed Glycine 0 C--N 1.34 0.763 0 C-N-CA 124.933 1.254 . . . . 0.0 112.096 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.82 158.43 38.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.401 1.48 . . . . 0.0 111.841 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 154.34 28.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.857 1.263 . . . . 0.0 111.843 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.7 m -130.39 132.62 45.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.176 2.19 . . . . 0.0 107.445 168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.84 134.85 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.693 0.797 . . . . 0.0 111.348 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.3 m -119.58 120.88 38.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.305 1.842 . . . . 0.0 109.759 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.429 ' CG ' ' HE2' ' A' ' 34' ' ' LYS . 49.9 p90 -148.97 171.3 16.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -101.15 108.7 55.93 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.963 2.105 . . . . 0.0 110.266 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.38 16.03 0.76 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 125.06 3.84 . . . . 0.0 113.805 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -121.23 -29.8 4.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.147 0.979 . . . . 0.0 111.534 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.04 -64.52 0.84 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 154.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.4 m -159.34 166.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.218 0.917 . . . . 0.0 111.975 -160.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -147.7 -144.24 0.15 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.972 0.909 . . . . 0.0 109.461 -166.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -61.1 -36.89 80.91 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.773 -1.204 . . . . 0.0 110.989 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mm -54.73 -46.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 0.0 112.237 -170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.6 m -64.6 -29.71 70.73 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.706 0.685 . . . . 0.0 112.718 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.259 17.6 tt -91.42 -25.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.901 0.88 . . . . 0.0 111.966 176.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -60.65 -48.98 79.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.097 1.759 . . . . 0.0 111.443 168.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.62 -37.53 70.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.474 1.11 . . . . 0.0 112.604 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -67.84 -54.38 19.44 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.187 1.395 . . . . 0.0 111.34 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.4 -32.46 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.593 -0.692 . . . . 0.0 111.894 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.05 85.91 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.854 0.862 . . . . 0.0 111.886 173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.33 -32.42 70.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.211 1.004 . . . . 0.0 112.941 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.37 -9.88 55.46 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.47 4.16 25.26 Favored Glycine 0 N--CA 1.473 1.157 0 C-N-CA 125.8 1.666 . . . . 0.0 115.343 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -114.12 -156.1 0.59 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.773 1.229 . . . . 0.0 111.643 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -168.55 145.81 3.93 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.096 2.159 . . . . 0.0 108.609 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -106.91 174.92 5.68 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.626 1.57 . . . . 0.0 114.255 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.46 138.1 27.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.332 1.053 . . . . 0.0 111.106 153.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.88 96.32 37.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.971 2.108 . . . . 0.0 108.446 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 123.643 2.895 . . . . 0.0 115.063 -167.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.417 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -85.02 161.24 19.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.223 0.609 . . . . 0.0 110.333 169.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -140.63 134.85 31.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.78 0.832 . . . . 0.0 111.852 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.76 144.74 29.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.658 0.783 . . . . 0.0 109.967 169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -163.37 173.64 12.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.175 0.99 . . . . 0.0 111.169 174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.48 174.82 5.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.87 1.268 . . . . 0.0 111.499 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.02 155.53 31.4 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.984 1.713 . . . . 0.0 112.043 169.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -84.75 145.54 27.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.738 0.815 . . . . 0.0 109.033 164.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.1 t -155.56 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.1 1.76 . . . . 0.0 108.547 -169.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -158.9 0.64 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.867 1.222 . . . . 0.0 114.587 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.25 28.5 0.33 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 -159.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -56.53 -17.11 7.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.928 1.864 . . . . 0.0 115.093 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -62.09 -12.68 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.5 m -53.38 155.14 2.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.544 1.138 . . . . 0.0 112.531 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 114.52 1.42 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.584 1.154 . . . . 0.0 112.997 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.56 -2.17 0.89 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.983 2.513 . . . . 0.0 115.557 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -67.38 -31.09 71.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.451 1.478 . . . . 0.0 112.877 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.72 22.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.27 1.428 . . . . 0.0 112.436 165.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 m -77.47 -30.78 53.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.197 -0.939 . . . . 0.0 112.137 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 m -68.41 -21.77 64.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.687 1.195 . . . . 0.0 112.473 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.8 mm -80.25 -62.68 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.505 -0.747 . . . . 0.0 109.769 160.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -70.57 -35.42 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.754 1.221 . . . . 0.0 114.194 -158.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -80.54 -48.96 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.667 0.667 . . . . 0.0 110.731 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.86 69.97 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.332 -0.855 . . . . 0.0 112.628 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.42 -21.1 34.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.822 1.249 . . . . 0.0 113.4 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -82.79 -35.15 26.72 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 112.357 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.7 mmt-85 -69.26 -15.94 63.47 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.849 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.68 -21.1 63.54 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 65.55 -5.37 0.48 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.981 2.113 . . . . 0.0 116.088 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.39 5.35 51.97 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 117.2 -1.889 . . . . 0.0 117.779 -171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.01 153.76 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 121.217 2.508 . . . . 0.0 112.357 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.87 9.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.401 1.081 . . . . 0.0 113.003 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.66 142.73 25.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.88 1.272 . . . . 0.0 110.551 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.37 145.21 8.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -152.15 129.36 11.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.851 1.26 . . . . 0.0 111.731 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.7 127.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.293 1.037 . . . . 0.0 109.348 174.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -91.52 105.96 18.14 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.76 -29.02 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.361 1.464 . . . . 0.0 111.964 -170.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.04 93.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.311 0.644 . . . . 0.0 112.257 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 -40.1 11.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.783 1.233 . . . . 0.0 111.89 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.62 48.91 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.122 1.344 . . . . 0.0 111.41 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -138.58 163.05 33.04 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.664 . . . . 0.0 110.388 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.02 156.45 28.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.024 0.93 . . . . 0.0 112.43 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 m -132.76 135.84 45.97 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.957 1.703 . . . . 0.0 107.91 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 p -150.3 143.41 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.206 1.003 . . . . 0.0 112.204 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -121.64 117.25 26.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.991 2.116 . . . . 0.0 109.85 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.43 158.81 44.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -92.56 114.01 61.15 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.853 2.061 . . . . 0.0 109.763 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.8 7.87 2.2 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.454 3.436 . . . . 0.0 114.287 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.69 -32.17 3.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.095 . . . . 0.0 112.175 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -74.46 -34.16 63.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.794 -0.622 . . . . 0.0 111.062 168.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.49 -170.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.394 0.997 . . . . 0.0 109.834 168.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.0 p -145.06 -178.34 6.0 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.333 -0.855 . . . . 0.0 110.541 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -40.51 -33.31 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.154 1.781 . . . . 0.0 113.826 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 mm -43.28 -49.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.549 1.94 . . . . 0.0 113.435 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.2 m -63.45 -31.7 72.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.274 0.63 . . . . 0.0 112.113 -171.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 tt -93.38 -30.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.237 0.926 . . . . 0.0 112.487 173.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -54.72 -47.46 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.955 1.302 . . . . 0.0 111.68 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.61 -39.82 88.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.977 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -49.23 78.6 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.484 1.038 . . . . 0.0 110.776 174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -64.59 -40.97 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.214 0.606 . . . . 0.0 110.722 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.88 -35.27 80.18 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.94 -24.79 55.5 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.829 1.252 . . . . 0.0 112.257 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.08 -15.21 62.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 165.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.32 12.25 57.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.809 1.195 . . . . 0.0 113.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -98.43 -170.97 2.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.669 1.187 . . . . 0.0 110.535 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 p -139.45 150.15 44.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.234 1.014 . . . . 0.0 110.822 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 tp -93.48 133.63 36.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.846 1.659 . . . . 0.0 111.888 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.83 76.14 1.62 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.931 1.693 . . . . 0.0 110.119 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -76.55 126.54 86.0 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.251 1.155 0 CA-C-N 119.997 1.035 . . . . 0.0 113.596 -160.029 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 CA--C 1.538 0.712 0 N-CA-C 113.542 0.555 . . . . 0.0 113.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.3 pt? -110.2 141.03 43.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.536 1.535 . . . . 0.0 110.133 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.3 pttt -108.77 151.28 26.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.176 0.99 . . . . 0.0 112.075 -172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 m -96.51 150.53 20.52 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.895 0.878 . . . . 0.0 109.447 164.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -157.46 149.77 22.72 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.329 1.451 . . . . 0.0 108.626 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -103.08 150.4 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.424 1.09 . . . . 0.0 109.007 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.85 143.57 33.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.226 -0.922 . . . . 0.0 112.702 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -82.26 134.53 35.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.507 167.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.6 t -156.03 122.15 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.378 2.271 . . . . 0.0 107.997 -166.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.75 -27.28 71.81 Favored Glycine 0 N--CA 1.475 1.257 0 N-CA-C 113.818 0.287 . . . . 0.0 113.818 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.41 32.85 3.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 126.4 1.952 . . . . 0.0 114.888 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.5 mmt -116.43 -33.55 4.89 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.39 1.095 . . . . 0.0 113.929 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -68.06 -18.02 64.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.6 t -97.03 128.9 44.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.865 1.266 . . . . 0.0 110.074 163.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.02 84.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.73 72.06 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.456 -0.777 . . . . 0.0 112.793 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -74.41 -50.88 16.75 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.025 -1.047 . . . . 0.0 112.061 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.5 -35.55 29.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.533 0.733 . . . . 0.0 111.774 169.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -77.11 -25.88 52.65 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.277 -0.89 . . . . 0.0 112.612 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.7 m -79.33 -22.59 44.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.496 1.118 . . . . 0.0 111.634 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -81.33 -54.73 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.417 0.687 . . . . 0.0 110.791 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.8 -34.29 77.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.018 0.826 . . . . 0.0 112.755 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -66.61 -20.85 66.1 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.228 -0.92 . . . . 0.0 112.58 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.92 -31.64 13.57 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.718 -1.239 . . . . 0.0 113.464 171.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.24 -19.0 61.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.72 -15.86 58.85 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -122.92 2.14 9.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.938 1.295 . . . . 0.0 114.486 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.91 -10.65 55.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 74.8 147.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.943 2.097 . . . . 0.0 113.386 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.01 -41.82 1.3 Allowed Glycine 0 N--CA 1.477 1.421 0 O-C-N 119.712 -1.867 . . . . 0.0 113.535 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 m -53.85 128.62 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.658 1.183 . . . . 0.0 110.63 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.59 -47.72 5.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.553 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -156.01 137.42 13.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.434 1.093 . . . . 0.0 110.63 -168.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.12 157.06 17.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.5 t -160.39 131.32 5.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.009 0.924 . . . . 0.0 112.308 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.93 153.33 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 112.58 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 t -130.7 126.04 35.47 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.317 1.047 . . . . 0.0 109.354 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.5 -37.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.392 1.477 . . . . 0.0 109.067 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.17 97.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.804 1.242 . . . . 0.0 112.534 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -84.8 -29.71 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.19 0.996 . . . . 0.0 111.103 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.0 49.54 9.62 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.453 1.025 . . . . 0.0 111.673 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -145.08 166.82 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.397 1.479 . . . . 0.0 111.167 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.69 147.39 40.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.183 0.993 . . . . 0.0 111.277 173.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 m -115.66 132.37 56.65 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 161.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -144.64 139.98 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.096 0.958 . . . . 0.0 111.523 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.3 m -112.28 125.89 54.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.423 2.289 . . . . 0.0 108.751 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -154.44 153.3 31.3 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.88 117.67 68.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 109.685 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.95 20.75 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.894 3.729 . . . . 0.0 113.769 -168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -141.28 -28.25 0.67 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.61 -51.53 69.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.04 0.836 . . . . 0.0 109.387 156.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.65 -176.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 110.498 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -148.15 -172.96 4.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.52 1.128 . . . . 0.0 109.518 171.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -40.63 -34.49 0.37 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.855 2.062 . . . . 0.0 114.031 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -47.79 -49.0 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.356 1.862 . . . . 0.0 112.162 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -57.37 -36.47 71.27 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.514 1.052 . . . . 0.0 112.891 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -95.41 -26.53 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.772 0.829 . . . . 0.0 112.342 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -59.38 -42.81 92.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.209 0.913 . . . . 0.0 110.85 165.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -62.89 4.09 0.19 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.378 1.871 . . . . 0.0 114.206 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -120.4 -45.79 2.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.276 1.43 . . . . 0.0 112.012 160.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.76 -41.09 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.654 1.57 . . . . 0.0 112.052 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.59 -15.07 59.94 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.47 -31.88 19.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.51 1.124 . . . . 0.0 111.965 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.8 tp -64.26 -28.97 70.09 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.63 0.772 . . . . 0.0 111.147 166.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.11 24.61 4.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.689 1.614 . . . . 0.0 114.364 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -115.48 -151.35 0.48 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.018 1.327 . . . . 0.0 110.597 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -166.54 148.7 6.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.092 2.557 . . . . 0.0 107.007 168.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.76 161.04 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.87 118.23 27.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.017 0.927 . . . . 0.0 111.057 165.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 109.35 37.7 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.44 1.496 . . . . 0.0 107.174 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.252 1.177 0 C-N-CA 123.663 2.909 . . . . 0.0 114.847 -161.505 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.536 0.59 0 N-CA-C 113.706 0.618 . . . . 0.0 113.706 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.43 154.02 46.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.946 1.298 . . . . 0.0 112.044 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -164.65 150.99 10.62 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -158.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -85.04 161.24 19.8 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.837 1.655 . . . . 0.0 113.661 -168.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -159.38 134.69 8.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.4 1.88 . . . . 0.0 108.747 -173.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -99.36 157.62 16.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 111.389 168.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.47 158.02 43.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.292 1.837 . . . . 0.0 111.063 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -90.49 157.33 17.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 162.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 129.2 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.414 1.486 . . . . 0.0 109.812 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.62 116.32 4.33 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.944 1.259 . . . . 0.0 111.397 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.66 -13.68 65.02 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.06 -1.967 . . . . 0.0 116.888 169.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -0.63 13.68 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 121.79 2.795 . . . . 0.0 115.354 -174.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -64.87 72.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.16 2.184 . . . . 0.0 115.079 -168.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -157.66 138.27 12.99 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.507 2.323 . . . . 0.0 109.783 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.89 67.75 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.6 -32.7 31.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 70.8 m -76.7 -32.98 58.22 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.049 -1.032 . . . . 0.0 112.983 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.19 -38.75 54.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.224 0.61 . . . . 0.0 111.658 161.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -71.95 -27.49 62.82 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.299 -0.876 . . . . 0.0 112.49 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -62.75 -36.0 81.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.323 1.42 . . . . 0.0 111.609 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.0 -58.42 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.19 -28.46 68.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -168.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -57.57 -32.06 66.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 112.902 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.54 -30.29 8.71 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.511 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.03 -36.21 62.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 121.069 1.759 . . . . 0.0 113.863 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -83.24 -3.31 57.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.448 -0.782 . . . . 0.0 112.918 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -108.0 -10.09 15.55 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.562 2.345 . . . . 0.0 113.308 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -69.06 138.98 54.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.684 1.129 . . . . 0.0 111.2 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -72.98 155.2 40.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.388 1.475 . . . . 0.0 112.391 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.58 -55.43 2.92 Favored Glycine 0 N--CA 1.475 1.297 0 C-N-CA 125.493 1.52 . . . . 0.0 113.559 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.37 142.49 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.567 1.547 . . . . 0.0 110.925 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.92 -51.79 2.34 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -163.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -155.87 141.58 17.93 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.881 1.219 . . . . 0.0 112.683 -171.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.3 179.32 8.64 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.0 t -167.46 139.19 3.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.865 1.666 . . . . 0.0 111.352 169.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.46 141.64 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.054 1.741 . . . . 0.0 109.704 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -122.07 91.62 3.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.517 1.527 . . . . 0.0 109.293 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.06 -39.18 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.685 1.594 . . . . 0.0 112.313 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.74 63.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.1 p -124.33 -0.26 8.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.883 1.673 . . . . 0.0 113.585 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.64 49.69 8.79 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.235 0.921 . . . . 0.0 112.925 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -132.1 167.55 19.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.647 1.179 . . . . 0.0 112.153 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.75 148.23 29.75 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.575 1.55 . . . . 0.0 109.966 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -130.97 135.94 48.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.441 1.496 . . . . 0.0 107.827 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 p -153.28 137.22 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.807 0.843 . . . . 0.0 112.771 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.9 m -111.23 130.87 55.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.283 2.233 . . . . 0.0 110.16 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.54 159.35 44.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -85.81 116.53 66.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.387 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.44 8.32 1.9 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.031 3.154 . . . . 0.0 113.196 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -113.88 -36.05 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.248 1.019 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -71.74 -39.65 69.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.913 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.78 178.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.78 0.832 . . . . 0.0 111.478 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 t -139.47 -174.51 3.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.222 1.409 . . . . 0.0 109.336 166.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -24.96 4.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 114.003 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mt -42.71 -39.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.931 1.692 . . . . 0.0 113.535 165.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 m -68.41 -33.87 75.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.554 1.142 . . . . 0.0 113.397 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.58 -29.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.688 0.676 . . . . 0.0 111.299 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.38 -50.36 71.79 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.438 1.495 . . . . 0.0 111.549 171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -65.51 -5.88 9.16 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -95.21 -53.33 3.83 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.055 0.942 . . . . 0.0 111.557 164.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.0 -43.89 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.24 0.927 . . . . 0.0 111.103 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.17 92.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.134 0.573 . . . . 0.0 112.218 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.98 -26.73 62.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 113.668 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -77.34 1.51 18.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.523 1.529 . . . . 0.0 112.638 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.23 3.17 79.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.323 1.439 . . . . 0.0 114.247 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -92.05 -174.04 3.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.948 1.299 . . . . 0.0 111.204 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 p -135.12 164.91 26.6 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.581 1.552 . . . . 0.0 108.805 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.87 166.09 23.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.72 77.61 1.51 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.377 1.471 . . . . 0.0 110.388 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -85.89 113.37 51.18 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 C--O 1.256 1.394 0 C-N-CA 121.715 1.61 . . . . 0.0 115.936 -158.348 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 CA--C 1.531 0.326 0 N-CA-C 112.699 0.231 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.09 146.72 24.64 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.59 0.756 . . . . 0.0 112.26 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -154.65 144.97 22.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -71.67 160.08 33.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.332 1.453 . . . . 0.0 111.985 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -166.53 136.73 3.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.452 1.901 . . . . 0.0 108.503 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -110.73 157.25 19.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.679 0.792 . . . . 0.0 111.864 166.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.7 ptp -150.3 163.59 37.91 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 112.532 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.3 151.47 19.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.505 0.722 . . . . 0.0 109.54 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.5 t -152.7 156.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.767 2.027 . . . . 0.0 108.82 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.64 -178.58 0.98 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.243 0.925 . . . . 0.0 114.689 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 68.21 0.93 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 125.587 1.565 . . . . 0.0 115.705 -164.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.4 mtm -64.46 -25.93 68.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.553 1.141 . . . . 0.0 113.937 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -84.84 166.73 16.65 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.697 1.199 . . . . 0.0 112.418 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m 67.64 35.13 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.207 2.203 . . . . 0.0 110.261 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 174.21 166.67 0.22 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 130.721 3.608 . . . . 0.0 110.656 -167.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.84 7.03 25.49 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.6 m -63.84 -25.38 68.14 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.316 -1.49 . . . . 0.0 115.016 -163.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -28.6 65.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.009 0.924 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.6 m -80.15 -40.22 27.8 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.192 -0.942 . . . . 0.0 111.289 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -60.93 -46.61 90.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.889 0.876 . . . . 0.0 112.318 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.92 -52.5 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.277 -0.89 . . . . 0.0 110.601 172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.65 -28.15 66.63 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -168.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -70.05 -30.3 67.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.959 0.904 . . . . 0.0 112.242 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.9 -24.07 18.56 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.87 -32.61 72.98 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.623 1.101 . . . . 0.0 113.215 -171.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.33 -10.12 59.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 113.913 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -93.39 -17.14 23.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.399 1.479 . . . . 0.0 113.157 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.88 -4.15 15.34 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.37 9.25 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.316 2.247 . . . . 0.0 116.285 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.79 -7.79 6.54 Favored Glycine 0 N--CA 1.476 1.332 0 C-N-CA 125.259 1.409 . . . . 0.0 115.873 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -110.56 122.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.517 1.527 . . . . 0.0 109.953 -172.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.35 -17.35 32.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.543 1.537 . . . . 0.0 114.179 -171.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.91 153.18 3.8 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.324 1.45 . . . . 0.0 109.864 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.61 156.27 7.86 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -149.41 119.32 7.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.415 1.886 . . . . 0.0 109.749 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.16 124.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.726 1.148 . . . . 0.0 107.917 165.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.3 m -87.7 97.59 10.97 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.304 1.441 . . . . 0.0 109.089 -171.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.08 -30.76 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.411 1.085 . . . . 0.0 113.057 -166.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.5 -63.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.346 0.976 . . . . 0.0 112.32 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -81.93 -25.27 35.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.368 1.867 . . . . 0.0 113.264 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.14 1.96 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.409 1.481 . . . . 0.0 110.166 -172.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -131.75 -174.67 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.565 2.346 . . . . 0.0 109.69 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.81 143.35 31.3 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.972 -1.08 . . . . 0.0 111.304 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.1 m -130.55 135.73 48.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.077 1.751 . . . . 0.0 108.715 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.15 141.6 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.366 1.066 . . . . 0.0 111.789 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -118.98 119.03 33.1 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.604 1.562 . . . . 0.0 109.747 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -150.32 171.11 17.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.28 1.032 . . . . 0.0 113.075 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.14 110.9 64.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.359 1.864 . . . . 0.0 110.594 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.14 8.04 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 125.065 3.843 . . . . 0.0 116.752 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.29 -45.92 2.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.726 0.694 . . . . 0.0 110.445 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.98 -32.75 74.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.323 -0.846 . . . . 0.0 112.11 174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.68 -171.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.5 1.52 . . . . 0.0 109.961 171.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.9 p -147.92 -171.12 3.75 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.021 -1.049 . . . . 0.0 111.143 170.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -45.96 -27.96 1.03 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.9 mm -49.31 -46.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.546 1.538 . . . . 0.0 112.286 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.9 m -53.74 -48.06 70.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 0.0 111.403 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.7 tt -86.53 -28.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.682 0.793 . . . . 0.0 112.713 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.1 -49.42 69.16 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.489 1.115 . . . . 0.0 111.346 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -56.87 -47.91 79.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.131 0.573 . . . . 0.0 112.505 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -69.64 -38.4 77.15 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.379 0.671 . . . . 0.0 111.864 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt -69.76 -40.17 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.664 0.665 . . . . 0.0 110.565 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.86 85.0 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.109 0.564 . . . . 0.0 112.303 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.27 -32.49 68.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 113.76 -174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.0 -5.57 44.7 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.041 0.837 . . . . 0.0 113.236 166.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.77 -5.28 20.69 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.271 1.891 . . . . 0.0 115.45 168.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -94.49 -159.38 0.7 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.957 1.379 . . . . 0.0 113.237 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -150.08 159.16 44.62 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.999 2.52 . . . . 0.0 108.852 166.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.95 167.99 9.94 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.96 87.08 1.74 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.023 2.129 . . . . 0.0 110.962 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.69 116.16 65.98 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.357 1.463 . . . . 0.0 107.896 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--O 1.255 1.361 0 C-N-CA 122.663 2.242 . . . . 0.0 115.063 -151.437 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 CA--C 1.534 0.491 0 CA-C-O 120.342 0.059 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.42 136.46 57.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -151.32 145.03 25.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.933 1.693 . . . . 0.0 112.565 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 t -85.03 155.95 21.32 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.329 1.451 . . . . 0.0 113.459 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -159.6 141.73 13.42 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.217 1.807 . . . . 0.0 110.295 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -98.67 156.26 16.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.101 1.36 . . . . 0.0 112.351 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.1 ptp -160.57 158.41 29.02 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.398 1.479 . . . . 0.0 113.399 173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -92.39 161.74 14.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.571 1.548 . . . . 0.0 110.204 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.8 p -163.1 119.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.282 -0.886 . . . . 0.0 111.286 -164.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.31 -11.57 79.67 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.44 -27.1 40.59 Favored Glycine 0 N--CA 1.471 1.022 0 CA-C-N 118.706 1.253 . . . . 0.0 113.961 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.13 137.79 58.34 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.965 0.882 . . . . 0.0 110.04 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 68.27 0.31 2.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.664 1.985 . . . . 0.0 115.423 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.09 -24.81 8.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.779 1.632 . . . . 0.0 113.253 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.11 6.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.519 1.927 . . . . 0.0 109.777 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 18.19 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.256 1.422 . . . . 0.0 114.327 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -53.11 -31.01 39.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.227 1.811 . . . . 0.0 115.561 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.41 -41.03 8.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.494 1.497 . . . . 0.0 112.919 167.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.24 -37.47 11.52 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.157 -0.964 . . . . 0.0 112.372 175.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -28.54 69.43 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.014 1.279 . . . . 0.0 113.064 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.46 -62.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 121.12 -0.988 . . . . 0.0 108.838 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -77.87 -21.9 50.64 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -156.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -77.32 -7.89 56.75 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.598 0.759 . . . . 0.0 112.866 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -110.34 -35.13 6.15 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.824 -1.173 . . . . 0.0 112.889 166.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.59 -38.05 77.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.75 -10.61 60.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.433 1.015 . . . . 0.0 113.696 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -103.19 -22.84 13.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.385 1.474 . . . . 0.0 113.001 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -54.6 128.91 34.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 111.882 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -55.43 109.01 0.48 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.416 1.086 . . . . 0.0 111.477 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.02 -5.73 39.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.506 1.527 . . . . 0.0 115.797 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.73 135.44 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.621 1.711 . . . . 0.0 109.952 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -116.74 -24.34 7.76 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -168.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -161.7 138.88 8.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.975 1.31 . . . . 0.0 108.813 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.03 143.64 19.44 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.848 1.204 . . . . 0.0 113.439 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.7 m -149.8 125.66 10.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.22 0.608 . . . . 0.0 111.505 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.98 158.24 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.309 -0.869 . . . . 0.0 111.428 167.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 m -132.63 105.82 7.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.736 1.214 . . . . 0.0 108.616 172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.64 -26.14 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.648 0.779 . . . . 0.0 112.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -29.31 70.72 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -120.84 -13.04 8.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.623 1.569 . . . . 0.0 112.879 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.98 71.04 1.18 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.106 1.812 . . . . 0.0 111.815 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -159.17 179.83 8.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.809 1.244 . . . . 0.0 111.813 -173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD13 HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -136.39 147.41 47.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.462 1.505 . . . . 0.0 110.874 -169.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 m -136.43 135.02 38.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.782 1.633 . . . . 0.0 108.771 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.41 141.72 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.785 0.834 . . . . 0.0 111.61 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.6 m -118.09 121.53 40.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.453 1.901 . . . . 0.0 109.316 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -152.84 164.63 37.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.745 1.618 . . . . 0.0 111.722 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -91.24 121.34 67.83 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 0.0 110.604 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.91 21.53 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.256 3.304 . . . . 0.0 113.595 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -124.53 -37.11 2.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.357 0.663 . . . . 0.0 112.073 170.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -61.9 -40.18 94.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.639 0.775 . . . . 0.0 111.33 164.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.6 177.47 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.162 0.892 . . . . 0.0 111.985 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -134.33 -171.98 2.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.268 1.427 . . . . 0.0 109.485 165.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.39 -28.26 2.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.962 0.905 . . . . 0.0 113.034 169.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.81 -35.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.463 1.505 . . . . 0.0 112.83 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 m -61.59 -41.25 97.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.771 0.714 . . . . 0.0 111.7 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 48' ' ' LEU . 19.4 tt -97.22 -33.35 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -47.95 -50.86 25.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.001 1.72 . . . . 0.0 111.653 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.35 -24.75 65.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.66 1.184 . . . . 0.0 113.458 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -54.4 18.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.595 1.089 . . . . 0.0 110.008 171.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.58 -38.0 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.791 -0.568 . . . . 0.0 110.544 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.16 94.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.35 62.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.351 1.06 . . . . 0.0 113.534 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -82.1 -0.18 43.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.532 1.533 . . . . 0.0 114.029 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.42 9.96 59.79 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 125.07 1.319 . . . . 0.0 114.787 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -120.49 -163.77 1.04 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.006 1.323 . . . . 0.0 111.331 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -143.73 138.1 28.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.617 1.167 . . . . 0.0 109.804 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -87.02 158.68 19.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.343 2.257 . . . . 0.0 111.497 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.72 122.2 16.17 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.264 -0.897 . . . . 0.0 111.36 168.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -99.76 110.04 57.67 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.253 1.237 0 C-N-CA 122.917 2.411 . . . . 0.0 115.28 -154.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 112.743 0.247 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.65 45.85 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.245 1.418 . . . . 0.0 111.186 -169.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -152.84 152.5 31.64 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -92.53 154.85 18.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.513 1.925 . . . . 0.0 110.778 -168.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -158.51 133.62 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.208 1.403 . . . . 0.0 108.659 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -107.32 146.56 31.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.586 1.154 . . . . 0.0 110.715 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.63 170.31 17.77 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.66 1.584 . . . . 0.0 112.925 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.64 161.1 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.189 1.396 . . . . 0.0 110.679 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.6 156.63 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.362 1.465 . . . . 0.0 108.833 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 -114.22 0.11 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.732 0.682 . . . . 0.0 112.288 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 8.34 0.57 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.4 ttp -71.26 3.72 3.41 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 120.541 2.171 . . . . 0.0 113.915 171.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -66.89 41.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 129.3 3.04 . . . . 0.0 115.552 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 45.5 t -155.01 139.41 16.77 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.924 2.09 . . . . 0.0 108.966 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.66 -39.88 74.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.748 0.819 . . . . 0.0 113.178 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.85 73.96 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.282 0.633 . . . . 0.0 111.851 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.88 -32.6 27.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.24 -40.73 62.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.945 0.793 . . . . 0.0 111.251 163.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -75.38 -21.77 58.01 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.902 -1.124 . . . . 0.0 112.844 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -73.65 -30.54 62.99 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.809 -1.182 . . . . 0.0 111.833 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.87 -56.79 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.628 164.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.54 -35.12 79.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.521 1.055 . . . . 0.0 113.177 -164.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -60.5 -43.85 96.61 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.263 0.483 . . . . 0.0 111.938 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.09 -31.58 25.24 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.781 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.34 -48.81 71.0 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 111.768 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -73.31 -17.4 61.31 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.716 -0.615 . . . . 0.0 112.221 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -92.94 -0.91 57.12 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.932 2.093 . . . . 0.0 113.252 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.1 mt -69.51 172.8 6.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.607 -1.308 . . . . 0.0 111.588 162.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.35 154.76 34.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.162 0.985 . . . . 0.0 112.528 172.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.38 -35.48 0.55 Allowed Glycine 0 N--CA 1.477 1.425 0 C-N-CA 125.821 1.677 . . . . 0.0 116.617 166.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 m -78.02 147.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.823 1.311 . . . . 0.0 111.886 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.4 -49.56 3.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.947 1.299 . . . . 0.0 113.812 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -162.11 147.34 12.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.866 0.757 . . . . 0.0 112.426 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.34 163.35 38.75 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.8 m -156.42 125.58 6.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.616 1.166 . . . . 0.0 112.915 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.8 150.45 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.121 1.368 . . . . 0.0 113.221 173.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.9 m -126.82 95.04 4.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.674 1.59 . . . . 0.0 108.381 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -72.61 -32.36 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.053 0.941 . . . . 0.0 112.816 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.09 -22.81 67.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.8 p -114.71 -24.4 8.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.606 1.562 . . . . 0.0 113.384 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.29 63.73 2.71 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -158.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -130.53 171.84 12.57 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.752 1.621 . . . . 0.0 110.261 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.51 147.63 24.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 110.295 -171.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.7 m -123.18 130.11 52.32 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.525 1.93 . . . . 0.0 106.892 173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.22 144.25 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.422 1.089 . . . . 0.0 110.675 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -116.13 129.91 56.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.583 1.953 . . . . 0.0 108.343 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.75 167.76 29.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.39 112.09 39.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.087 1.355 . . . . 0.0 108.743 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.81 7.22 2.47 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.333 2.689 . . . . 0.0 112.813 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -109.63 -45.23 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.144 0.978 . . . . 0.0 109.472 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -66.13 -38.54 88.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.046 1.338 . . . . 0.0 111.665 170.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 m -146.65 178.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.775 1.17 . . . . 0.0 113.738 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.2 p -155.56 -159.14 0.89 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.781 2.032 . . . . 0.0 110.902 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -47.82 -29.41 3.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.447 1.099 . . . . 0.0 113.468 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -54.88 -52.88 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.192 1.797 . . . . 0.0 112.222 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.2 m -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.04 0.536 . . . . 0.0 111.851 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.3 tt -82.29 -34.76 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.195 0.998 . . . . 0.0 111.907 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -55.52 -48.34 74.82 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.553 1.07 . . . . 0.0 110.504 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -53.71 -22.58 9.37 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -90.31 -47.43 7.76 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.775 1.23 . . . . 0.0 111.521 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.79 -45.76 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.709 1.14 . . . . 0.0 110.776 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -23.52 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.43 -33.35 20.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.237 1.415 . . . . 0.0 112.137 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.91 -9.88 59.3 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.95 18.08 5.67 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 115.864 1.106 . . . . 0.0 115.864 164.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.59 -168.06 1.96 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.804 1.241 . . . . 0.0 110.513 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 m -137.89 141.05 40.68 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.025 1.33 . . . . 0.0 109.805 168.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.14 148.58 21.89 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.863 2.065 . . . . 0.0 111.306 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 117.4 12.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.447 1.099 . . . . 0.0 113.203 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.92 90.55 50.19 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.213 1.805 . . . . 0.0 106.728 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.456 3.437 . . . . 0.0 115.583 -159.359 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 CA--C 1.538 0.683 0 N-CA-C 112.765 0.256 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -158.07 155.18 28.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.504 1.121 . . . . 0.0 111.555 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -135.17 135.77 41.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.616 0.766 . . . . 0.0 112.07 -169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -80.12 160.48 25.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.264 1.025 . . . . 0.0 111.982 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -162.16 147.21 12.73 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.997 1.719 . . . . 0.0 109.13 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -108.24 133.67 52.15 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.824 1.249 . . . . 0.0 108.686 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 ttm -134.58 145.52 48.75 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.517 1.127 . . . . 0.0 110.67 -162.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.12 155.01 18.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.359 0.664 . . . . 0.0 110.874 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.88 106.44 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.269 1.428 . . . . 0.0 110.013 -166.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.44 101.18 1.24 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 124.297 0.951 . . . . 0.0 112.104 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.5 -18.01 7.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 126.074 1.797 . . . . 0.0 114.787 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 38.4 ttp -87.43 126.6 34.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.39 1.595 . . . . 0.0 108.912 170.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 167.06 156.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.602 2.761 . . . . 0.0 110.763 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m 75.05 -58.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.804 2.442 . . . . 0.0 114.172 168.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.51 145.36 12.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.126 1.37 . . . . 0.0 112.494 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.69 -166.15 0.15 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.823 2.449 . . . . 0.0 115.138 166.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m 76.64 -30.15 0.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.804 2.441 . . . . 0.0 115.661 159.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -54.24 -26.16 27.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.376 1.87 . . . . 0.0 113.271 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -50.48 -39.03 47.07 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.398 . . . . 0.0 113.296 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -73.9 -13.87 60.97 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.254 -0.904 . . . . 0.0 113.123 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.67 -59.76 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.791 1.236 . . . . 0.0 108.73 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.94 -40.22 72.16 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.902 0.774 . . . . 0.0 112.48 -163.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -65.6 -20.15 66.2 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.529 0.604 . . . . 0.0 112.391 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.5 -34.33 13.43 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 112.964 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 tp -62.51 -23.7 67.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.247 1.019 . . . . 0.0 113.352 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.14 -3.31 32.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -118.26 -28.51 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.023 1.729 . . . . 0.0 113.971 -176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.5 mt -55.27 159.47 2.62 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.575 1.15 . . . . 0.0 113.149 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.69 150.6 45.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.436 1.095 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.4 -31.6 0.57 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.656 1.598 . . . . 0.0 116.918 166.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.24 132.54 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.453 1.501 . . . . 0.0 111.292 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.14 -19.95 9.48 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.101 1.36 . . . . 0.0 114.609 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -165.55 131.46 2.61 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.492 1.117 . . . . 0.0 110.697 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.17 160.82 35.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.4 t -159.26 137.73 10.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.42 HG21 ' HB1' ' A' ' 23' ' ' ALA . 31.1 m -86.33 146.99 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.905 0.882 . . . . 0.0 111.638 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.1 m -129.67 97.92 4.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.4 1.48 . . . . 0.0 108.477 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.19 -38.69 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.111 0.964 . . . . 0.0 111.677 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.18 65.96 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -120.18 3.63 10.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.055 1.742 . . . . 0.0 112.611 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.74 46.77 93.83 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.762 1.649 . . . . 0.0 114.426 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -140.68 164.29 30.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.077 1.439 . . . . 0.0 113.906 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.32 159.27 21.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.224 2.209 . . . . 0.0 111.415 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.9 m -135.62 132.95 37.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.093 2.157 . . . . 0.0 106.116 170.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.76 132.16 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.2 m -119.28 119.26 33.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.23 2.212 . . . . 0.0 109.059 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.35 153.17 38.25 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.276 1.03 . . . . 0.0 112.87 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.0 134.87 48.92 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 121.814 -0.554 . . . . 0.0 110.971 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.08 10.87 2.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.155 2.57 . . . . 0.0 113.372 -171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -123.98 -35.67 2.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.978 1.263 . . . . 0.0 113.588 -165.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.03 -27.98 48.96 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.037 0.935 . . . . 0.0 112.19 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.6 m -147.41 -178.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.589 1.156 . . . . 0.0 111.072 -176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -139.1 -163.82 1.55 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.801 1.64 . . . . 0.0 110.423 166.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.05 -26.74 6.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.247 1.019 . . . . 0.0 112.72 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mm -51.83 -46.48 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.817 1.647 . . . . 0.0 113.095 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.4 m -58.3 -40.26 81.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.695 0.798 . . . . 0.0 111.878 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 tt -88.33 -31.95 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.406 0.683 . . . . 0.0 112.558 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -55.94 -45.65 78.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.535 1.134 . . . . 0.0 111.427 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -63.87 -36.17 83.04 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.315 1.046 . . . . 0.0 112.943 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -72.21 -40.76 67.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.145 1.378 . . . . 0.0 111.337 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.58 -47.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 118.853 0.751 . . . . 0.0 110.594 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.47 -54.67 32.83 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.341 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.18 72.28 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.97 -1.03 42.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.424 1.09 . . . . 0.0 113.232 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.61 6.4 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-O 118.827 -0.985 . . . . 0.0 115.226 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -124.33 -172.0 2.46 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.43 1.492 . . . . 0.0 111.632 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -142.49 127.39 18.3 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.359 . . . . 0.0 111.245 173.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.7 142.13 48.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.449 1.5 . . . . 0.0 111.884 176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.05 135.35 46.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.49 0.716 . . . . 0.0 110.776 153.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -130.97 123.57 20.03 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.617 1.567 . . . . 0.0 109.033 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 123.474 2.782 . . . . 0.0 113.734 -164.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.536 0.581 0 CA-C-O 120.905 0.294 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.22 178.58 6.12 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 112.955 -170.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -99.19 147.67 24.88 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.689 0.796 . . . . 0.0 112.655 -171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.6 m -124.43 149.3 46.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.411 1.885 . . . . 0.0 108.87 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -149.66 152.06 34.75 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.655 -0.653 . . . . 0.0 111.04 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -124.08 147.96 47.47 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.543 1.937 . . . . 0.0 109.698 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.72 149.56 14.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.05 142.22 32.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.278 0.631 . . . . 0.0 109.811 161.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -149.2 130.4 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.833 1.653 . . . . 0.0 109.829 -168.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -26.77 72.63 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 122.022 -0.424 . . . . 0.0 113.307 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.18 12.53 6.86 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.73 1.634 . . . . 0.0 115.263 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 68.5 mmm -122.47 -0.69 9.21 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.2 ptt85 -153.87 -15.46 0.14 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -165.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -83.16 -24.26 32.58 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 0.0 112.98 172.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -166.85 175.76 7.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.014 2.126 . . . . 0.0 111.552 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 25.9 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 127.406 2.282 . . . . 0.0 115.805 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.38 -11.9 60.63 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.13 51.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.614 1.097 . . . . 0.0 113.825 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m -66.46 -44.58 82.35 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.062 0.846 . . . . 0.0 111.181 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 m -76.37 -4.93 44.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.299 1.44 . . . . 0.0 113.722 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.0 -63.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.022 156.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -62.97 -39.18 93.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.091 0.859 . . . . 0.0 112.585 -165.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -60.28 -30.82 69.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.199 1.0 . . . . 0.0 113.317 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.67 -42.64 9.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.731 1.212 . . . . 0.0 111.532 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.2 tp -59.6 -36.16 75.74 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 112.78 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -79.33 -5.12 53.8 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -108.72 -36.78 6.07 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.87 149.01 51.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.911 0.884 . . . . 0.0 112.845 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -69.27 158.32 35.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 113.41 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.45 -42.1 2.99 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.594 1.568 . . . . 0.0 113.218 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 136.45 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.823 1.249 . . . . 0.0 109.406 164.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.73 -20.61 5.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.74 145.12 12.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.033 1.733 . . . . 0.0 108.758 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.25 150.7 18.49 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.543 -1.348 . . . . 0.0 113.667 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.6 m -147.12 109.44 4.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.54 1.136 . . . . 0.0 111.176 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.65 138.55 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.737 -0.602 . . . . 0.0 109.813 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.9 m -119.6 95.32 4.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.961 1.305 . . . . 0.0 108.819 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.21 -37.66 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.029 0.932 . . . . 0.0 112.59 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -41.22 98.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 p -102.32 -11.4 18.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.147 1.779 . . . . 0.0 112.722 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.57 38.67 43.32 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.838 1.685 . . . . 0.0 113.498 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -118.88 -178.36 3.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.28 1.432 . . . . 0.0 112.137 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 154.92 44.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.053 0.941 . . . . 0.0 111.858 -173.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -137.17 134.95 36.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.51 1.924 . . . . 0.0 107.533 168.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -146.04 143.12 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.831 0.852 . . . . 0.0 110.891 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.9 m -126.74 134.62 50.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.13 2.172 . . . . 0.0 108.729 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -161.07 155.86 23.71 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.332 1.053 . . . . 0.0 113.25 -164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.17 112.22 42.02 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.746 1.218 . . . . 0.0 109.418 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.71 12.86 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.8 3.0 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -119.65 -31.19 4.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.791 1.236 . . . . 0.0 112.71 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -98.37 -16.37 19.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 166.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.01 178.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.462 1.505 . . . . 0.0 110.178 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 p -141.52 -162.85 1.45 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.025 0.93 . . . . 0.0 110.574 164.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -18.36 3.0 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 168.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.0 mm -52.59 -38.05 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.813 1.245 . . . . 0.0 112.838 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -70.25 -42.43 72.2 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.365 0.984 . . . . 0.0 112.549 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.3 tt -71.42 -35.11 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.354 0.979 . . . . 0.0 111.947 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -43.62 75.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.96 0.8 . . . . 0.0 111.08 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -71.75 -13.84 61.83 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -93.91 -44.75 7.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.684 1.129 . . . . 0.0 110.531 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.07 -42.42 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.194 -0.941 . . . . 0.0 111.443 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.93 88.97 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 112.124 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.84 66.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.185 0.994 . . . . 0.0 112.534 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -75.01 -4.81 40.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.334 1.453 . . . . 0.0 113.117 169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.95 9.34 45.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.543 2.02 . . . . 0.0 115.645 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.09 -161.65 0.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.204 1.502 . . . . 0.0 112.64 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p -139.0 176.89 8.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.814 1.646 . . . . 0.0 109.827 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 pt? -124.19 161.96 24.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.294 1.838 . . . . 0.0 111.898 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 93.75 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 110.344 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -93.5 120.64 66.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.254 1.276 0 C-N-CA 121.548 1.499 . . . . 0.0 114.996 -152.06 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 CA--C 1.537 0.668 0 N-CA-C 114.028 0.741 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.23 162.64 29.18 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.414 1.086 . . . . 0.0 111.343 178.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -111.28 136.95 49.63 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.172 0.589 . . . . 0.0 111.675 177.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -103.76 153.96 20.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.232 1.013 . . . . 0.0 109.607 167.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -157.82 144.69 17.98 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -172.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -123.2 160.87 25.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.092 0.957 . . . . 0.0 110.333 170.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -160.23 150.38 18.25 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -88.39 125.93 34.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.501 0.72 . . . . 0.0 110.141 173.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -140.92 131.39 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.243 1.817 . . . . 0.0 108.798 -165.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.39 150.34 41.79 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.062 1.315 . . . . 0.0 113.709 -170.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.29 -7.94 5.66 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.021 1.772 . . . . 0.0 116.74 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.3 mmt -63.44 -22.82 67.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.801 1.801 . . . . 0.0 115.004 -169.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -71.41 -18.15 62.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.304 1.411 . . . . 0.0 113.943 171.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.19 163.3 19.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.861 1.265 . . . . 0.0 112.543 -171.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.13 120.93 5.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.332 1.453 . . . . 0.0 113.273 -170.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 6.86 1.42 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 115.404 174.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.13 -37.31 75.27 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.898 -1.126 . . . . 0.0 113.815 -168.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.02 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 172.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -37.87 87.27 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.943 0.792 . . . . 0.0 111.605 -174.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.0 m -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.293 -0.879 . . . . 0.0 112.93 -174.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.2 -53.59 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.64 -29.07 65.33 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -166.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -58.59 -28.7 65.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.332 1.053 . . . . 0.0 113.185 174.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.81 -38.12 8.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.206 1.002 . . . . 0.0 112.959 173.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 tp -48.47 -41.71 30.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -165.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.84 -6.9 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -115.78 0.72 13.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.446 1.499 . . . . 0.0 113.486 170.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.54 114.33 2.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -59.66 -25.41 64.7 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -152.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.44 87.99 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-O 118.344 -1.253 . . . . 0.0 116.204 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -92.92 132.45 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 119.23 1.515 . . . . 0.0 110.376 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.45 -27.74 12.61 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.667 1.587 . . . . 0.0 114.338 -177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.53 147.74 2.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.69 1.596 . . . . 0.0 111.986 171.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -168.65 159.86 10.3 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -170.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -162.89 128.89 3.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.207 0.603 . . . . 0.0 111.916 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.86 119.45 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 m -90.42 96.86 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.047 0.939 . . . . 0.0 108.615 -177.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.37 -37.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.702 0.801 . . . . 0.0 112.289 -173.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.79 -6.56 49.6 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -174.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -124.17 -17.22 6.24 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.209 1.804 . . . . 0.0 112.41 171.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.46 55.92 13.54 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.54 2.019 . . . . 0.0 112.371 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -152.19 172.37 16.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.059 1.344 . . . . 0.0 112.258 174.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 149.75 50.17 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.107 0.963 . . . . 0.0 112.573 -164.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.6 m -136.28 136.08 39.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.384 2.273 . . . . 0.0 107.817 173.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.07 143.33 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.098 1.359 . . . . 0.0 110.861 -175.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.8 m -125.04 125.52 43.95 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.341 1.857 . . . . 0.0 108.941 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -143.55 163.49 33.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.974 1.31 . . . . 0.0 114.001 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.2 115.38 64.59 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.565 1.146 . . . . 0.0 109.577 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.46 7.87 2.46 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.142 3.228 . . . . 0.0 113.474 -171.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -121.8 -23.28 5.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.852 1.261 . . . . 0.0 111.56 -179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -84.41 -37.38 21.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.66 163.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -151.03 -169.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 119.87 1.214 . . . . 0.0 113.176 -171.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -154.79 -167.73 2.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.616 1.966 . . . . 0.0 110.868 171.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -55.82 -16.3 4.34 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.643 -1.286 . . . . 0.0 114.371 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.03 -33.94 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.607 -1.308 . . . . 0.0 113.026 171.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 m -60.0 -39.27 85.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.158 0.983 . . . . 0.0 112.093 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.69 -29.97 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.908 0.883 . . . . 0.0 112.781 -177.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -50.72 -56.48 11.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.331 1.053 . . . . 0.0 110.631 170.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -63.34 -35.53 80.68 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.647 -175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.78 -41.88 97.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.134 1.374 . . . . 0.0 112.304 175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -72.12 -47.6 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.538 . . . . 0.0 110.332 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.9 -41.79 91.02 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.17 73.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.985 0.914 . . . . 0.0 113.154 -176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.84 8.53 6.63 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.262 1.025 . . . . 0.0 113.135 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.33 4.97 59.44 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.971 1.272 . . . . 0.0 114.453 168.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.0 -169.54 1.72 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.478 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -146.13 167.55 23.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.765 1.626 . . . . 0.0 110.587 -175.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.23 165.94 33.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.9 112.22 13.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.255 1.022 . . . . 0.0 110.082 159.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.5 87.81 17.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 166.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.254 1.283 0 C-N-CA 122.973 2.449 . . . . 0.0 114.355 -171.288 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 CA--C 1.542 0.883 0 CA-C-O 119.842 -0.149 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.1 pt? -71.73 142.03 49.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 113.547 177.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -143.29 149.99 38.6 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.818 2.047 . . . . 0.0 111.019 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -77.65 153.91 32.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.629 1.171 . . . . 0.0 111.813 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -158.39 150.99 22.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.883 1.673 . . . . 0.0 109.779 -176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -124.6 158.26 33.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.448 1.099 . . . . 0.0 111.28 170.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.47 164.88 37.72 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.984 1.314 . . . . 0.0 111.97 172.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -90.3 148.01 23.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.504 0.721 . . . . 0.0 109.202 165.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -113.59 127.91 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.117 1.367 . . . . 0.0 109.856 171.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.59 103.44 2.54 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.993 1.282 . . . . 0.0 111.8 -172.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.44 -12.39 47.44 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.92 1.724 . . . . 0.0 115.28 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -101.15 122.82 44.29 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.138 1.969 . . . . 0.0 110.819 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -162.71 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.358 1.463 . . . . 0.0 113.148 176.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.95 143.32 46.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.333 1.453 . . . . 0.0 110.768 173.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.73 -30.54 68.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.459 -0.776 . . . . 0.0 112.249 175.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.74 58.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 173.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.1 t -117.42 -21.37 8.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.03 -40.1 29.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.408 1.458 . . . . 0.0 111.464 162.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.0 m -64.08 -24.56 67.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.665 0.786 . . . . 0.0 112.995 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -80.12 -21.85 42.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.72 1.208 . . . . 0.0 112.376 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.16 -60.59 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 164.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -63.18 -36.83 84.94 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.08 0.952 . . . . 0.0 112.762 -163.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -67.5 -47.14 70.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.864 0.756 . . . . 0.0 111.785 -178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.34 69.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.455 0.702 . . . . 0.0 112.716 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -59.18 -38.43 79.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -168.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.39 -16.77 62.42 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.512 1.051 . . . . 0.0 113.262 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -100.69 -10.21 21.1 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.413 1.485 . . . . 0.0 113.278 177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.53 142.15 58.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.167 1.349 . . . . 0.0 111.239 169.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.39 128.33 35.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.431 0.692 . . . . 0.0 112.452 -174.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.0 71.52 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.542 1.544 . . . . 0.0 115.007 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.34 138.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.272 1.429 . . . . 0.0 110.72 -174.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.48 -24.8 6.68 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -172.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -163.85 138.43 5.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.593 1.557 . . . . 0.0 109.734 -176.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.91 157.07 25.9 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.109 1.322 . . . . 0.0 114.465 177.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.5 p -166.37 149.38 7.08 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.488 1.115 . . . . 0.0 113.922 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.46 157.87 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.804 1.242 . . . . 0.0 113.586 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -123.19 94.14 4.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.809 1.644 . . . . 0.0 107.409 152.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.48 -36.26 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.769 0.828 . . . . 0.0 112.751 -172.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.49 -41.09 63.09 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 p -118.5 3.92 11.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.458 1.903 . . . . 0.0 112.943 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.61 42.24 27.25 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 125.117 1.342 . . . . 0.0 113.456 173.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -111.9 165.08 12.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.274 1.029 . . . . 0.0 113.721 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.6 mt -131.74 161.23 33.32 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.255 2.222 . . . . 0.0 110.671 175.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.8 m -129.0 138.49 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.686 2.394 . . . . 0.0 106.292 166.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.48 142.69 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.507 1.123 . . . . 0.0 110.876 -177.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.1 m -119.56 115.05 23.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.12 1.768 . . . . 0.0 109.086 177.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.15 176.05 10.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.543 1.937 . . . . 0.0 110.798 177.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.24 104.18 14.49 Favored Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.782 -1.199 . . . . 0.0 109.224 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.86 20.16 0.64 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.899 3.066 . . . . 0.0 113.002 -173.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -131.18 -28.85 1.88 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 169.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -82.92 -24.95 32.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.63 1.104 . . . . 0.0 112.649 168.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.77 -164.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.578 1.551 . . . . 0.0 108.846 163.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -153.11 -176.34 5.74 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.81 -1.181 . . . . 0.0 111.343 173.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -49.05 -22.26 0.87 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.449 1.5 . . . . 0.0 113.029 169.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.12 -40.89 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.207 1.403 . . . . 0.0 113.78 170.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.5 m -59.31 -48.25 82.34 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.045 0.839 . . . . 0.0 111.219 -177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 tt -77.81 -33.74 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.664 1.186 . . . . 0.0 112.09 177.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -58.85 -53.33 59.59 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 124.185 0.994 . . . . 0.0 111.302 177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.57 -15.09 62.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -47.13 13.48 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.884 1.22 . . . . 0.0 109.609 169.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.32 -40.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.956 -1.09 . . . . 0.0 111.872 -175.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.22 66.45 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.106 1.762 . . . . 0.0 113.182 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.75 -44.38 11.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.143 0.977 . . . . 0.0 112.1 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -54.71 -22.47 14.03 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.645 1.578 . . . . 0.0 114.484 174.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.77 13.46 3.72 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.527 1.537 . . . . 0.0 115.08 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -117.46 -171.5 2.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.919 1.359 . . . . 0.0 113.081 -170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.9 p -128.76 170.1 13.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.728 1.611 . . . . 0.0 109.591 167.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.4 tp -120.14 148.86 43.11 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.992 0.917 . . . . 0.0 112.337 -178.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.31 81.18 1.74 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.169 0.988 . . . . 0.0 113.063 177.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -84.05 106.41 7.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 162.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.387 2.725 . . . . 0.0 115.724 -147.284 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 N--CA 1.48 0.729 0 CA-C-O 118.995 -0.502 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.43 146.23 47.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.138 0.881 . . . . 0.0 112.072 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -157.92 151.96 24.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.274 1.43 . . . . 0.0 112.596 -168.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 m -77.42 150.13 35.05 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.1 0.96 . . . . 0.0 110.835 177.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -148.05 144.73 28.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.623 1.569 . . . . 0.0 108.542 170.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -125.59 145.99 49.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 175.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.77 163.82 34.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.448 1.499 . . . . 0.0 112.229 -176.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -82.2 143.86 31.1 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 159.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.79 106.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.705 1.202 . . . . 0.0 107.943 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.91 128.36 8.55 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.475 1.512 . . . . 0.0 112.886 -164.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -4.89 74.98 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.39 1.472 . . . . 0.0 114.021 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.9 ttp -70.76 116.34 10.96 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.467 1.133 . . . . 0.0 111.482 179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -134.47 178.22 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.07 1.748 . . . . 0.0 110.985 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.9 -50.1 73.54 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.361 1.464 . . . . 0.0 114.5 -170.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.65 -40.45 69.03 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -158.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.42 -36.15 0.19 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -55.58 -49.5 72.56 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.283 0.947 . . . . 0.0 112.706 -174.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.24 -19.39 1.21 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.98 1.712 . . . . 0.0 115.243 172.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -100.97 -49.08 4.23 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.387 0.994 . . . . 0.0 111.596 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.0 m -68.47 -25.42 64.97 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.733 -1.229 . . . . 0.0 113.226 -173.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.22 -59.61 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.664 0.786 . . . . 0.0 109.698 163.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.23 -34.86 73.38 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -161.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -65.33 -36.54 84.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.658 0.663 . . . . 0.0 112.057 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.95 -24.21 30.78 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -59.29 -31.18 68.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.587 1.085 . . . . 0.0 113.099 -173.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.3 -8.78 58.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.718 1.207 . . . . 0.0 114.147 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.09 -15.86 17.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.442 1.497 . . . . 0.0 113.473 177.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.68 149.05 50.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.581 0.705 . . . . 0.0 112.472 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -48.46 126.09 10.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.423 1.089 . . . . 0.0 112.253 178.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.2 -6.19 37.65 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.709 -1.606 . . . . 0.0 116.267 169.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -80.08 130.35 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.732 1.766 . . . . 0.0 110.608 -178.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.68 -37.2 7.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.539 1.535 . . . . 0.0 114.223 -175.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.89 136.55 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.736 1.215 . . . . 0.0 114.236 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.27 154.71 21.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.725 1.21 . . . . 0.0 112.852 -167.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -152.1 141.13 21.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.7 m -79.3 152.09 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.804 1.241 . . . . 0.0 112.41 176.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 46.9 m -125.48 95.17 4.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 108.169 167.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 t -63.27 -32.63 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.599 0.76 . . . . 0.0 112.101 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.4 -35.88 8.97 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.749 1.62 . . . . 0.0 114.962 -177.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.1 p -132.79 -1.28 3.4 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.369 1.868 . . . . 0.0 113.458 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.55 50.13 64.3 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.913 0.768 . . . . 0.0 111.212 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.8 mtp85 -127.75 159.41 34.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.858 1.263 . . . . 0.0 109.533 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.84 143.26 28.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.247 0.619 . . . . 0.0 109.654 -169.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -125.12 130.33 51.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.18 1.792 . . . . 0.0 108.131 176.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.3 142.31 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.221 1.408 . . . . 0.0 111.46 -172.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -110.91 121.46 45.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.754 1.622 . . . . 0.0 109.796 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.13 167.99 28.01 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.997 1.319 . . . . 0.0 113.117 -178.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.64 118.62 65.99 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.271 1.428 . . . . 0.0 110.379 176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.6 7.5 3.07 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.442 3.428 . . . . 0.0 113.899 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -121.25 -32.76 3.82 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.724 0.693 . . . . 0.0 112.291 176.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -64.13 -39.85 94.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.544 164.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.67 176.96 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.706 1.202 . . . . 0.0 110.804 176.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 p -127.94 -174.28 3.16 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.492 -0.755 . . . . 0.0 111.199 163.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.83 -14.54 0.21 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 167.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.49 -38.71 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.322 -1.486 . . . . 0.0 113.14 169.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 m -64.17 -41.03 97.3 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 112.115 -176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.91 -34.92 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.908 0.483 . . . . 0.0 111.583 173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -58.46 -42.83 88.32 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.891 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -54.96 -46.04 74.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.751 1.614 . . . . 0.0 112.405 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.47 -41.82 83.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.05 1.34 . . . . 0.0 111.833 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -69.73 -46.07 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.565 -0.709 . . . . 0.0 111.0 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.03 95.52 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.613 1.165 . . . . 0.0 112.796 -176.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.86 70.01 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.503 1.121 . . . . 0.0 112.583 -177.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.6 -1.78 43.63 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.32 9.12 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 124.627 1.108 . . . . 0.0 114.977 172.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.8 -174.25 2.99 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.685 1.594 . . . . 0.0 111.738 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -142.23 168.38 19.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.207 1.403 . . . . 0.0 110.823 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tt -138.82 145.4 40.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.447 -175.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.86 118.25 13.75 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.672 1.189 . . . . 0.0 111.684 169.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -122.35 123.77 27.03 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.036 1.734 . . . . 0.0 108.616 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.119 3.213 . . . . 0.0 115.841 -156.251 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 119.503 -0.291 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.93 164.46 12.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.612 1.165 . . . . 0.0 113.487 173.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -169.87 151.89 4.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.039 1.336 . . . . 0.0 112.173 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -86.22 160.15 19.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.893 0.877 . . . . 0.0 113.074 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -166.41 141.77 4.55 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.805 2.042 . . . . 0.0 108.779 -173.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -108.76 159.13 17.0 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.347 0.659 . . . . 0.0 112.014 167.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.7 ptm -144.22 160.52 40.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.051 1.74 . . . . 0.0 111.634 -175.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.57 150.84 20.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.178 0.991 . . . . 0.0 108.732 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.57 143.58 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.654 1.181 . . . . 0.0 110.159 -169.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 114.06 2.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.699 1.143 . . . . 0.0 112.7 -176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.56 5.38 34.12 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.588 1.566 . . . . 0.0 116.154 173.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -89.82 147.23 23.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.479 2.14 . . . . 0.0 114.0 178.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -149.0 177.07 9.9 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.516 2.327 . . . . 0.0 110.704 176.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.23 -54.2 49.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.742 1.217 . . . . 0.0 112.335 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.55 118.94 8.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.005 0.522 . . . . 0.0 110.754 177.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.46 -66.65 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.451 2.3 . . . . 0.0 113.691 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.62 -52.27 65.85 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.194 0.906 . . . . 0.0 112.89 -160.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -57.54 -14.98 5.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.804 2.042 . . . . 0.0 114.494 172.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 m -95.52 -55.15 3.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.534 0.734 . . . . 0.0 110.666 170.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -56.91 -43.8 81.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.062 1.301 . . . . 0.0 113.107 -171.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.7 -33.29 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.464 0.706 . . . . 0.0 111.969 178.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -97.47 -25.69 15.09 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.947 1.299 . . . . 0.0 113.029 -176.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -67.5 -39.72 85.19 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.754 -1.216 . . . . 0.0 110.479 169.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.84 -31.44 63.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.473 1.109 . . . . 0.0 113.512 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -44.35 -58.9 2.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.037 1.335 . . . . 0.0 111.303 178.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -76.19 -14.2 60.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -171.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -85.68 -34.18 21.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.447 1.899 . . . . 0.0 111.903 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.262 1.1 pp -86.35 6.19 31.15 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 175.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.4 mttm 75.92 -34.1 0.23 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.63 2.372 . . . . 0.0 116.587 158.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.07 5.64 83.55 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 117.029 1.572 . . . . 0.0 117.029 -165.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.12 141.18 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.043 1.922 . . . . 0.0 111.501 -172.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.97 -34.41 19.29 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -169.35 147.16 3.62 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.704 1.202 . . . . 0.0 109.545 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.44 158.15 39.54 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.52 0.6 . . . . 0.0 111.887 168.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.1 t -156.93 119.05 3.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.827 -0.546 . . . . 0.0 111.9 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 23' ' ' ALA . 8.7 p -62.35 154.35 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.612 0.765 . . . . 0.0 111.571 171.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m -122.7 94.03 4.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.213 1.405 . . . . 0.0 107.637 168.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 t -63.56 -40.59 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.014 0.926 . . . . 0.0 112.269 -173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.57 -41.38 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.839 1.256 . . . . 0.0 113.625 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -110.22 -3.87 16.04 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.457 1.503 . . . . 0.0 113.004 -176.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 45.24 96.89 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.119 0.872 . . . . 0.0 112.623 -170.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -122.4 -176.94 3.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.488 1.515 . . . . 0.0 111.462 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.37 150.94 33.25 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.358 1.063 . . . . 0.0 111.782 -172.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.3 m -131.42 143.78 50.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.12 1.768 . . . . 0.0 108.516 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 p -150.78 137.8 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.256 1.023 . . . . 0.0 112.268 -173.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -105.0 121.3 43.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.231 1.813 . . . . 0.0 108.496 165.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -140.6 155.42 46.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.435 0.694 . . . . 0.0 112.62 174.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -87.31 112.47 48.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.626 1.57 . . . . 0.0 108.773 172.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.47 13.08 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.293 3.329 . . . . 0.0 113.078 -172.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -120.57 -43.13 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.0 110.014 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -62.73 -40.14 96.29 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.476 166.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.68 -167.55 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.309 1.044 . . . . 0.0 111.77 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 p -146.19 -178.45 6.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.413 1.485 . . . . 0.0 110.1 172.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.66 -22.83 0.19 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.744 1.617 . . . . 0.0 114.511 169.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.9 mt -56.41 -37.25 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.226 1.81 . . . . 0.0 112.874 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.0 m -79.22 -5.77 55.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.118 . . . . 0.0 113.08 -175.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 tt -108.74 -30.15 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 117.455 -1.26 . . . . 0.0 113.39 160.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.26 -56.44 12.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.851 1.205 . . . . 0.0 112.113 174.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -70.0 -32.53 70.76 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.017 -0.516 . . . . 0.0 111.608 -170.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -60.27 -16.86 37.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 168.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.51 -44.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.57 1.077 . . . . 0.0 109.748 175.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.23 -31.05 63.91 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.319 1.048 . . . . 0.0 113.508 -176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.31 -38.69 30.17 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.965 -1.084 . . . . 0.0 112.513 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -7.07 43.83 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.968 1.307 . . . . 0.0 113.23 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.88 9.9 9.56 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.276 1.417 . . . . 0.0 115.547 166.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.64 -164.53 1.07 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.389 1.476 . . . . 0.0 112.491 -168.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -146.72 176.18 10.05 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.566 -1.334 . . . . 0.0 111.226 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.53 165.71 35.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.792 1.637 . . . . 0.0 114.009 -168.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.55 125.1 6.97 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.965 1.706 . . . . 0.0 110.7 160.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -122.79 95.67 46.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.891 1.276 . . . . 0.0 108.094 171.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.377 3.384 . . . . 0.0 113.375 -176.092 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.478 0.591 0 CA-C-O 120.084 -0.048 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -54.43 142.21 27.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.453 0.701 . . . . 0.0 112.198 168.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -144.7 147.42 33.0 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.837 1.255 . . . . 0.0 110.885 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 m -94.78 148.06 22.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.535 1.534 . . . . 0.0 109.888 -174.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -161.95 164.62 28.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.566 1.146 . . . . 0.0 109.819 177.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -137.55 156.68 47.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.326 1.05 . . . . 0.0 112.034 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.57 167.78 29.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 112.298 -171.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -96.49 168.24 10.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.936 1.294 . . . . 0.0 111.429 178.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.5 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.484 -0.76 . . . . 0.0 112.942 -170.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 143.15 34.13 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.539 0.59 . . . . 0.0 111.695 171.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.21 -19.85 2.78 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 117.894 1.918 . . . . 0.0 117.894 170.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -78.55 9.47 3.99 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 121.555 2.678 . . . . 0.0 115.855 -170.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.91 160.0 19.52 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.714 1.143 . . . . 0.0 111.841 173.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.9 t 72.63 -73.91 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.28 2.232 . . . . 0.0 112.735 170.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -174.44 1.93 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.328 2.251 . . . . 0.0 113.868 -172.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.84 9.58 7.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.734 1.613 . . . . 0.0 114.658 174.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.5 m -53.12 -42.48 66.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.154 1.782 . . . . 0.0 114.668 -174.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.07 -31.56 13.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.5 1.52 . . . . 0.0 112.587 173.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 m -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -177.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 m -73.11 -12.96 61.09 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.818 -1.176 . . . . 0.0 112.641 173.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.0 mm -92.4 -53.46 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.41 1.084 . . . . 0.0 109.272 166.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -60.34 -42.35 95.5 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.499 1.12 . . . . 0.0 112.435 -172.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -56.5 -31.49 64.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 113.048 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -34.47 15.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.21 . . . . 0.0 112.23 173.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.24 -20.39 63.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.948 1.299 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.86 -7.18 57.67 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.283 0.947 . . . . 0.0 113.28 165.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -115.81 -20.19 10.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.78 160.46 4.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.179 1.354 . . . . 0.0 112.994 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -70.04 157.98 36.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 167.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.36 -38.6 1.01 Allowed Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.744 1.64 . . . . 0.0 115.921 171.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.85 148.26 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.306 1.442 . . . . 0.0 111.751 171.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.06 -15.56 1.97 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.968 1.307 . . . . 0.0 114.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -160.52 150.36 17.74 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.152 1.381 . . . . 0.0 108.755 173.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.95 159.78 18.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.276 1.031 . . . . 0.0 111.767 176.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 m -163.92 141.61 7.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.859 1.263 . . . . 0.0 112.209 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.2 m -95.19 154.47 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.245 1.418 . . . . 0.0 111.158 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.7 m -131.46 94.67 3.59 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.64 -30.14 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.138 1.375 . . . . 0.0 111.342 -177.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.0 -35.88 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.992 -1.068 . . . . 0.0 113.825 -176.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.8 p -114.49 -14.74 12.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.328 1.851 . . . . 0.0 112.89 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.12 60.56 4.1 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -175.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -124.83 165.37 18.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.392 1.077 . . . . 0.0 111.484 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 150.46 50.18 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.542 1.537 . . . . 0.0 109.821 168.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.4 m -132.34 135.12 45.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.357 1.863 . . . . 0.0 106.743 173.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.26 142.41 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.048 0.939 . . . . 0.0 111.078 -168.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -117.35 116.74 27.79 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.767 2.027 . . . . 0.0 108.06 173.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -142.76 158.45 43.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.086 0.954 . . . . 0.0 113.511 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.13 118.96 69.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.562 1.545 . . . . 0.0 110.672 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.49 8.38 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.253 3.302 . . . . 0.0 113.469 -172.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -114.29 -40.95 3.56 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.676 1.19 . . . . 0.0 110.272 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -65.0 -39.8 93.99 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.5 168.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.96 -179.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 119.634 1.106 . . . . 0.0 112.505 -176.08 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -140.97 -175.56 4.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.548 1.539 . . . . 0.0 109.736 164.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.79 -36.38 1.45 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.238 1.415 . . . . 0.0 114.41 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -38.06 -49.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.857 1.663 . . . . 0.0 112.99 170.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 m -62.17 -35.17 78.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.003 0.921 . . . . 0.0 112.735 -172.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 tt -94.26 -33.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 111.826 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -51.08 -49.94 59.68 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 111.236 170.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.18 -30.72 69.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.167 1.387 . . . . 0.0 113.546 175.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -76.36 -41.49 48.0 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.018 1.281 . . . . 0.0 111.391 177.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.05 -42.36 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.21 0.914 . . . . 0.0 110.977 172.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.97 77.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.157 0.583 . . . . 0.0 112.151 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.57 -20.34 58.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.261 0.937 . . . . 0.0 113.115 179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.1 mm? -79.19 -1.03 34.35 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 162.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.06 1.62 67.05 Favored Glycine 0 N--CA 1.473 1.136 0 C-N-CA 125.724 1.63 . . . . 0.0 114.645 171.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -97.52 -151.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.154 1.382 . . . . 0.0 111.815 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.3 132.66 10.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.734 0.814 . . . . 0.0 112.203 175.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 tp -83.92 139.37 32.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.482 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.89 89.79 3.17 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.12 1.368 . . . . 0.0 111.327 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -129.55 106.67 17.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.995 1.718 . . . . 0.0 108.291 175.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.981 3.121 . . . . 0.0 113.501 -176.468 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 CA-C-O 119.886 -0.131 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.04 147.16 43.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.832 0.825 . . . . 0.0 111.958 -178.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -149.06 147.2 28.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.381 1.472 . . . . 0.0 111.263 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -83.38 157.19 22.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.212 0.605 . . . . 0.0 110.824 173.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -156.4 136.62 12.91 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.9 1.28 . . . . 0.0 108.581 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -86.25 157.27 19.98 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.569 0.748 . . . . 0.0 111.004 168.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.8 ttm -156.29 139.56 15.66 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.343 1.057 . . . . 0.0 111.05 -165.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -91.85 157.36 16.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.937 1.695 . . . . 0.0 108.68 173.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.28 136.85 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.936 1.294 . . . . 0.0 110.858 172.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 129.49 9.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.008 1.29 . . . . 0.0 110.87 176.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 -21.5 9.32 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.191 1.853 . . . . 0.0 115.981 174.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 ttp -81.2 119.43 23.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.35 2.075 . . . . 0.0 110.43 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -171.47 12.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.452 1.901 . . . . 0.0 115.283 178.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.37 155.24 28.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.992 1.317 . . . . 0.0 111.677 164.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.56 76.19 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.12 -56.36 21.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.053 0.941 . . . . 0.0 111.838 174.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 p -66.93 -42.82 84.69 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.462 -0.774 . . . . 0.0 112.64 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -52.79 -30.53 33.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.207 1.003 . . . . 0.0 112.388 171.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -76.85 -25.61 53.36 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.102 -0.998 . . . . 0.0 113.382 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -83.67 -24.35 31.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.444 1.097 . . . . 0.0 111.811 176.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.58 -65.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.34 -40.94 77.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -156.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.28 -13.48 60.77 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.63 -31.78 15.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.545 1.138 . . . . 0.0 112.805 167.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.84 -16.4 61.22 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.267 1.427 . . . . 0.0 113.413 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.22 -4.84 59.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 113.716 168.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -114.64 -16.27 11.86 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.384 1.474 . . . . 0.0 113.864 175.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.0 mt -59.81 141.19 55.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.255 0.934 . . . . 0.0 110.856 165.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -80.35 168.51 18.93 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.056 0.942 . . . . 0.0 111.407 178.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -35.92 0.82 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 119.988 -1.695 . . . . 0.0 115.732 177.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.82 141.87 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.777 2.031 . . . . 0.0 110.383 169.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.86 -33.79 5.0 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.162 1.385 . . . . 0.0 114.27 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -167.53 129.23 1.55 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.684 1.594 . . . . 0.0 110.851 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.8 166.06 30.6 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.18 -0.95 . . . . 0.0 112.839 -177.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -159.14 135.02 8.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' HB1' ' A' ' 23' ' ' ALA . 32.8 m -83.98 145.49 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.849 1.66 . . . . 0.0 111.507 168.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.8 m -121.75 103.69 9.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.204 1.402 . . . . 0.0 107.906 167.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.7 -43.56 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.08 0.952 . . . . 0.0 112.455 -169.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.63 70.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -170.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 p -107.91 -3.34 18.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.622 1.569 . . . . 0.0 112.112 169.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.36 58.43 9.49 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 125.924 1.726 . . . . 0.0 112.822 170.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -145.49 176.91 9.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.067 1.347 . . . . 0.0 112.509 -170.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.33 160.61 38.57 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.581 1.153 . . . . 0.0 113.861 -168.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -137.86 135.79 36.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.029 2.532 . . . . 0.0 107.455 165.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.38 135.53 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.616 0.766 . . . . 0.0 112.177 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 m -110.54 122.06 46.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.744 2.018 . . . . 0.0 109.274 176.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -153.88 162.53 41.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.617 1.167 . . . . 0.0 112.439 -178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -92.52 114.42 62.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.959 1.303 . . . . 0.0 110.448 171.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.41 9.86 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.352 3.368 . . . . 0.0 116.32 -177.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -122.5 -34.44 3.26 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.284 0.947 . . . . 0.0 112.261 177.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -75.04 -29.44 60.76 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.531 168.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.13 -159.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.218 1.407 . . . . 0.0 109.557 168.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -160.8 -170.81 2.86 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.175 1.79 . . . . 0.0 109.977 177.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -49.98 -29.4 8.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.7 -43.06 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 112.693 -178.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -58.11 -40.38 81.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.143 0.977 . . . . 0.0 112.302 -175.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.4 tt -87.06 -30.22 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.162 0.985 . . . . 0.0 112.476 174.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -58.9 -51.91 68.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.721 0.809 . . . . 0.0 112.2 175.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.88 -25.28 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.397 0.679 . . . . 0.0 112.128 -176.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -69.07 -49.54 56.47 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.207 -0.933 . . . . 0.0 111.09 169.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.72 -38.06 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.311 -0.868 . . . . 0.0 111.348 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.34 79.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.882 1.273 . . . . 0.0 112.598 -179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.95 -31.87 72.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 113.293 177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.12 -9.47 58.12 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.96 6.61 39.72 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 125.288 1.423 . . . . 0.0 114.671 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -107.53 -174.53 2.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.092 2.157 . . . . 0.0 110.863 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 p -150.48 123.63 8.85 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.582 1.083 . . . . 0.0 111.751 170.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.91 159.74 33.24 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.09 128.0 33.28 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.317 1.056 . . . . 0.0 111.115 158.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.15 77.53 17.96 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 175.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.769 2.979 . . . . 0.0 114.334 -163.326 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 112.655 0.213 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -158.11 138.15 12.37 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.365 1.466 . . . . 0.0 110.463 -177.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -112.23 143.16 43.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.8 m -97.94 141.99 30.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.489 1.915 . . . . 0.0 108.915 177.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -156.95 140.83 16.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.021 0.828 . . . . 0.0 110.275 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -86.14 146.26 26.66 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.579 1.552 . . . . 0.0 110.525 168.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 ptp -147.5 163.9 35.08 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.243 -0.911 . . . . 0.0 112.507 176.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -97.44 159.28 15.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.727 1.211 . . . . 0.0 110.875 175.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -156.4 139.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.533 1.533 . . . . 0.0 111.221 -171.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.02 34.33 3.97 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.247 1.403 . . . . 0.0 116.127 -170.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.65 15.74 0.02 OUTLIER Glycine 0 N--CA 1.479 1.502 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 176.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.7 mmt -90.01 2.32 55.3 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.061 1.931 . . . . 0.0 115.757 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 ptm85 -67.22 24.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 t -141.84 126.63 18.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.885 2.474 . . . . 0.0 109.601 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.26 82.6 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.745 1.218 . . . . 0.0 112.658 -173.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.96 -25.72 61.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.027 0.931 . . . . 0.0 113.347 171.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.4 m -96.34 -34.64 11.5 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.985 0.914 . . . . 0.0 113.091 177.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.98 -38.13 16.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 112.604 171.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.1 m -64.49 -35.04 79.65 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.885 -0.509 . . . . 0.0 112.172 -177.106 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -74.65 -20.69 59.79 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.192 -0.942 . . . . 0.0 112.189 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.3 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 124.512 1.125 . . . . 0.0 109.254 160.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.64 -30.43 68.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -159.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -63.06 -45.77 90.64 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.782 0.719 . . . . 0.0 111.691 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.18 -32.37 33.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.093 0.86 . . . . 0.0 112.798 -170.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.54 -13.1 62.16 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -107.1 -12.59 15.37 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.231 1.812 . . . . 0.0 113.91 -174.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.78 115.67 3.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.798 1.181 . . . . 0.0 110.301 171.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -65.97 119.71 11.82 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.994 -1.067 . . . . 0.0 111.224 -175.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.42 -17.02 40.7 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.019 1.771 . . . . 0.0 114.124 -166.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.2 t -104.02 133.75 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.381 1.472 . . . . 0.0 107.75 166.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.16 -32.53 6.28 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -167.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -161.14 135.32 7.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.39 0.995 . . . . 0.0 111.796 -176.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.75 163.26 40.09 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -174.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 t -161.42 139.32 9.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.384 -0.822 . . . . 0.0 112.711 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.48 130.17 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.993 1.317 . . . . 0.0 110.797 171.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -91.14 102.17 14.91 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.218 1.407 . . . . 0.0 108.122 168.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -75.93 -36.32 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.028 0.931 . . . . 0.0 112.463 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.95 -12.7 61.24 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.0 p -121.28 -22.39 6.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.289 1.836 . . . . 0.0 112.688 173.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.55 49.76 29.23 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.432 1.491 . . . . 0.0 111.84 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -113.22 166.56 11.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.499 1.12 . . . . 0.0 111.517 169.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.25 161.21 22.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.9 1.68 . . . . 0.0 111.551 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.5 m -142.02 135.5 29.31 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.732 2.013 . . . . 0.0 107.037 169.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.01 140.21 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 111.321 -175.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.2 m -113.27 119.52 37.98 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.129 2.172 . . . . 0.0 108.444 172.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -144.13 154.23 42.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -174.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.81 109.87 30.49 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.747 1.619 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.48 14.53 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.464 3.443 . . . . 0.0 113.626 -170.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -121.36 -33.75 3.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.941 1.296 . . . . 0.0 111.155 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -73.6 -39.21 64.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.921 0.489 . . . . 0.0 111.702 168.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.17 171.15 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.458 0.703 . . . . 0.0 111.86 -174.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.2 m -134.75 -175.53 3.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.052 1.341 . . . . 0.0 109.103 167.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -21.33 3.43 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -42.07 -46.0 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.404 2.281 . . . . 0.0 113.978 164.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -71.62 -44.99 63.4 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.866 0.866 . . . . 0.0 112.554 -173.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -69.91 -30.53 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.351 -0.843 . . . . 0.0 111.313 173.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -61.92 -41.11 97.56 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.148 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.64 -30.18 60.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.043 1.292 . . . . 0.0 113.908 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -56.3 4.72 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.906 1.282 . . . . 0.0 111.217 171.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.59 -40.77 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.579 -0.701 . . . . 0.0 111.608 -172.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.08 -30.59 71.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.738 0.815 . . . . 0.0 112.146 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -24.95 30.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.643 1.577 . . . . 0.0 113.268 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.85 -15.58 63.69 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 121.662 -0.649 . . . . 0.0 112.645 160.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.59 39.13 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 126.136 1.827 . . . . 0.0 114.801 174.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -99.6 -164.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.675 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.9 p -142.47 169.92 16.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 109.118 172.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.91 164.45 20.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.69 121.9 16.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.765 0.826 . . . . 0.0 112.867 169.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 97.38 14.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.891 2.076 . . . . 0.0 107.411 174.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 C--O 1.253 1.23 0 C-N-CA 123.823 3.015 . . . . 0.0 114.494 -162.289 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 120.158 -0.018 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.96 150.37 24.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.111 0.958 . . . . 0.0 110.73 173.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -129.42 130.54 46.09 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.505 1.122 . . . . 0.0 110.646 177.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -93.63 155.34 17.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.138 1.375 . . . . 0.0 110.064 168.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -173.19 155.92 3.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.693 1.197 . . . . 0.0 111.028 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.32 151.15 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.838 0.855 . . . . 0.0 111.233 161.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -125.06 152.29 44.51 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.822 1.649 . . . . 0.0 110.698 169.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -90.06 128.51 36.31 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 t -133.19 151.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.067 1.747 . . . . 0.0 109.962 -172.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.19 -127.58 0.84 Allowed Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.839 1.209 . . . . 0.0 114.112 -176.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.49 13.59 1.13 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.889 . . . . 0.0 117.103 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.71 -12.98 19.01 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.291 1.436 . . . . 0.0 113.751 177.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.99 57.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.057 2.943 . . . . 0.0 115.819 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.2 t -157.36 143.76 17.95 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.111 1.764 . . . . 0.0 109.169 168.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.18 66.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -167.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.05 96.43 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.714 -0.616 . . . . 0.0 111.681 176.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.6 m -67.88 -48.38 66.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.764 0.826 . . . . 0.0 112.939 -174.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.53 -29.01 65.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.28 0.491 . . . . 0.0 112.283 168.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -76.9 -36.51 56.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.479 -0.763 . . . . 0.0 111.31 178.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -64.87 -24.0 67.4 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.483 -1.386 . . . . 0.0 112.889 174.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 mp -77.98 -59.13 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.867 0.867 . . . . 0.0 110.304 163.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -70.88 -31.14 67.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.843 0.747 . . . . 0.0 112.964 -163.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.81 -34.12 52.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.621 1.168 . . . . 0.0 112.168 172.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.99 -40.53 15.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.899 0.88 . . . . 0.0 112.25 171.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.05 -26.8 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -174.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -75.11 -12.52 60.33 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.457 -0.777 . . . . 0.0 112.817 171.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -111.14 -19.04 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.3 mt -58.34 -27.1 63.85 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -171.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 68.41 159.91 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.804 2.041 . . . . 0.0 113.215 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.45 -41.74 1.18 Allowed Glycine 0 N--CA 1.481 1.661 0 O-C-N 120.091 -1.631 . . . . 0.0 113.503 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.28 142.1 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 144.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.67 -41.63 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.954 1.301 . . . . 0.0 113.743 -170.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -148.09 138.0 22.53 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.22 1.808 . . . . 0.0 108.695 178.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.38 147.01 21.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.039 1.29 . . . . 0.0 113.787 -176.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -145.77 109.53 4.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.581 1.152 . . . . 0.0 112.118 -177.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.36 154.79 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.266 1.026 . . . . 0.0 111.701 168.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -136.52 105.59 5.96 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.086 1.355 . . . . 0.0 109.037 175.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.52 -38.96 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.6 1.56 . . . . 0.0 112.398 -177.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.65 67.69 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -120.22 -13.63 8.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.823 2.049 . . . . 0.0 112.904 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.31 60.9 3.88 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.274 0.94 . . . . 0.0 111.624 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -140.63 174.36 10.59 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.264 1.025 . . . . 0.0 112.406 178.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.56 147.65 48.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.918 0.887 . . . . 0.0 111.395 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -118.32 131.94 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.957 2.103 . . . . 0.0 106.651 168.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 p -146.64 138.33 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.344 0.658 . . . . 0.0 111.82 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 m -112.82 128.85 56.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.18 2.192 . . . . 0.0 108.307 170.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -150.0 164.22 36.05 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -100.58 111.27 62.55 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.906 1.682 . . . . 0.0 108.792 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.05 17.57 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.859 3.039 . . . . 0.0 113.568 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -127.25 -25.37 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 112.264 172.003 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -71.5 -40.8 69.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.973 -1.079 . . . . 0.0 110.96 160.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.77 -163.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.634 1.174 . . . . 0.0 110.679 178.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.9 p -153.84 -171.77 4.0 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.247 1.819 . . . . 0.0 109.903 172.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -48.12 -34.32 9.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.817 0.847 . . . . 0.0 112.781 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 mm -47.48 -48.57 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.628 1.971 . . . . 0.0 113.323 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 m -57.64 -43.1 84.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.65 0.78 . . . . 0.0 111.285 -172.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.98 -30.22 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.215 1.006 . . . . 0.0 112.903 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -55.98 -49.69 72.89 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.349 1.06 . . . . 0.0 111.394 175.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.11 -50.01 67.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.819 0.848 . . . . 0.0 112.685 -178.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.96 -39.07 79.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.398 0.679 . . . . 0.0 112.113 -176.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.96 -39.82 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.646 1.112 . . . . 0.0 111.185 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.74 -39.24 90.92 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.195 0.452 . . . . 0.0 112.024 174.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.89 89.06 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -4.47 21.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 171.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.22 7.51 43.25 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.614 1.102 . . . . 0.0 114.894 170.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -97.29 -164.68 1.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.952 1.376 . . . . 0.0 111.698 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 p -146.13 171.21 15.25 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.214 1.806 . . . . 0.0 109.942 175.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.43 168.67 24.13 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.665 1.186 . . . . 0.0 113.623 -174.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.27 140.07 16.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.601 1.561 . . . . 0.0 112.492 172.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.82 69.44 11.06 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.274 1.83 . . . . 0.0 109.221 178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.379 3.386 . . . . 0.0 114.962 -155.8 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 0.89 0 N-CA-C 113.644 0.594 . . . . 0.0 113.644 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp -107.69 -172.09 2.0 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.249 1.82 . . . . 0.0 110.585 172.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -143.08 147.84 35.69 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.125 0.97 . . . . 0.0 112.616 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -110.08 167.27 10.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.096 1.358 . . . . 0.0 110.43 174.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -162.7 146.77 11.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.617 1.167 . . . . 0.0 109.007 -177.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -134.35 138.09 44.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.511 1.524 . . . . 0.0 108.888 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.9 ptm -157.66 156.95 32.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.033 0.933 . . . . 0.0 112.645 -159.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -82.92 145.04 29.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.619 1.167 . . . . 0.0 111.032 169.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.44 150.85 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.298 1.039 . . . . 0.0 110.916 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.93 93.66 1.58 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.487 1.518 . . . . 0.0 112.548 -177.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.96 -20.96 3.99 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.63 1.586 . . . . 0.0 116.097 168.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.46 -30.36 64.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.899 1.849 . . . . 0.0 114.556 -168.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -45.99 113.96 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.359 1.063 . . . . 0.0 113.527 -174.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.9 m 58.56 24.87 12.45 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.529 1.931 . . . . 0.0 114.452 173.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.92 21.81 2.46 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -167.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.04 -4.63 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.6 5.56 0.29 Allowed 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 43' ' ' VAL . . . -65.61 -30.11 70.79 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.447 -1.408 . . . . 0.0 112.96 167.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 m -56.04 -45.06 79.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 p -62.94 -46.74 86.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 112.565 175.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.77 -48.27 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.048 1.739 . . . . 0.0 111.176 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.54 -17.37 59.28 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.312 1.045 . . . . 0.0 111.17 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -78.83 -36.56 42.32 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.366 -1.459 . . . . 0.0 111.894 173.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.32 -21.33 59.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 174.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 tp -50.58 -44.66 56.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.735 1.214 . . . . 0.0 114.022 -176.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -70.41 -15.07 62.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 113.211 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -85.7 -36.54 20.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.769 0.828 . . . . 0.0 112.437 179.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt -52.86 155.69 2.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.513 1.525 . . . . 0.0 114.465 -179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -100.87 165.75 11.19 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.895 1.678 . . . . 0.0 112.381 162.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.82 11.07 59.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.701 1.619 . . . . 0.0 116.518 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.45 152.46 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.291 1.437 . . . . 0.0 110.951 -172.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.28 -49.85 1.92 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 113.639 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -151.16 151.32 31.76 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.623 1.569 . . . . 0.0 109.223 -177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.38 145.68 2.71 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.103 0.961 . . . . 0.0 112.472 176.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -152.01 123.73 7.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.464 1.105 . . . . 0.0 111.299 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.05 151.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.772 0.829 . . . . 0.0 108.924 167.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 m -126.61 88.25 2.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.954 1.302 . . . . 0.0 108.652 173.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 23' ' ' ALA . 4.3 t -57.54 -29.18 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 112.312 173.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.13 68.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.8 p -130.14 -4.35 4.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.591 1.556 . . . . 0.0 113.699 -178.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.02 33.45 32.98 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 119.443 1.02 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -121.44 174.2 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.55 1.54 . . . . 0.0 111.572 -172.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.1 151.08 30.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.118 1.367 . . . . 0.0 110.815 -172.011 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -131.94 138.03 48.18 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.766 2.426 . . . . 0.0 107.34 172.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.08 140.6 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.197 0.999 . . . . 0.0 111.652 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -132.23 128.59 38.22 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.182 2.193 . . . . 0.0 109.856 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.91 160.25 42.05 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.477 1.511 . . . . 0.0 113.048 -173.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.7 124.25 61.15 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 121.179 -0.951 . . . . 0.0 111.41 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.7 8.84 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.947 3.098 . . . . 0.0 112.99 -174.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -106.14 -38.75 6.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.021 0.928 . . . . 0.0 111.11 -173.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.25 -30.71 14.43 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.584 1.154 . . . . 0.0 112.042 171.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -143.88 -168.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.725 1.148 . . . . 0.0 111.938 -173.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -163.78 -153.91 0.25 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.8 1.24 . . . . 0.0 108.769 -178.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -52.64 -19.84 2.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -53.12 -29.96 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 120.692 -1.255 . . . . 0.0 112.417 173.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.6 m -59.05 -24.07 62.55 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.83 2.452 . . . . 0.0 113.585 173.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.76 -37.77 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -49.04 -66.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 127.316 2.246 . . . . 0.0 111.933 174.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -64.32 -30.47 71.52 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.486 0.714 . . . . 0.0 112.104 -173.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -76.58 -31.54 57.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.766 1.226 . . . . 0.0 112.391 -177.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.52 -49.16 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.806 0.73 . . . . 0.0 110.341 171.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.21 38.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.996 0.519 . . . . 0.0 112.033 -172.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.68 61.22 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.77 -8.2 59.29 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.98 0.912 . . . . 0.0 112.276 173.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.22 9.55 5.51 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.593 1.568 . . . . 0.0 116.302 159.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -114.49 -172.11 2.05 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.597 1.199 . . . . 0.0 111.844 -170.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.9 p -135.93 170.93 15.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.456 1.102 . . . . 0.0 110.393 175.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.13 159.67 41.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.14 65.25 1.38 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.051 1.341 . . . . 0.0 110.846 169.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -83.79 124.3 75.11 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.045 1.83 . . . . 0.0 116.325 -152.843 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 112.82 0.277 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 pp -154.22 152.05 29.89 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.26 1.024 . . . . 0.0 111.86 -176.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -149.39 150.46 32.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.327 1.451 . . . . 0.0 111.47 -172.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.02 163.41 20.99 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.36 0.664 . . . . 0.0 111.912 178.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -164.06 135.68 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 109.675 -171.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -87.68 136.05 33.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 110.101 169.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.9 ttm -125.32 133.12 52.72 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 109.72 177.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -89.6 140.51 29.48 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 t -147.75 142.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.514 1.125 . . . . 0.0 110.256 -172.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.96 108.71 2.78 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.804 1.193 . . . . 0.0 113.309 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.45 -2.06 7.62 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 164.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.35 -9.22 52.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.369 2.085 . . . . 0.0 114.549 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -105.74 -11.48 16.27 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.346 0.976 . . . . 0.0 113.512 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -67.99 -19.69 64.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.961 1.304 . . . . 0.0 113.965 174.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.14 155.4 20.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.389 2.276 . . . . 0.0 108.48 172.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.69 102.75 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.252 0.933 . . . . 0.0 111.059 177.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.8 m -137.8 -4.97 1.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.07 1.748 . . . . 0.0 114.77 -170.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.92 -42.62 17.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.679 1.127 . . . . 0.0 112.176 173.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.3 m -72.97 -26.52 61.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.32 -0.862 . . . . 0.0 112.645 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -19.39 61.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.278 -1.514 . . . . 0.0 111.757 176.15 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.63 -59.88 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.656 1.182 . . . . 0.0 110.07 161.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -72.61 -17.9 61.64 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -163.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -82.31 -9.47 59.46 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 0.0 112.879 171.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.96 -33.64 9.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.572 166.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.54 2.5 1.28 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -169.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -117.46 -16.96 10.16 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.738 1.215 . . . . 0.0 113.006 165.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -69.82 -29.06 66.24 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.326 1.05 . . . . 0.0 110.614 168.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.7 mt -61.77 153.62 28.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.074 0.949 . . . . 0.0 112.83 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.54 162.05 27.42 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.725 1.21 . . . . 0.0 112.044 172.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.75 -36.38 0.48 Allowed Glycine 0 N--CA 1.481 1.675 0 C-N-CA 125.876 1.703 . . . . 0.0 117.198 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -61.74 156.61 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 126.44 1.896 . . . . 0.0 112.407 173.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.22 -30.96 0.71 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -171.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -169.04 117.84 0.67 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.109 1.322 . . . . 0.0 111.146 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.65 157.0 43.62 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.5 m -148.99 124.32 10.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 112.339 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.13 132.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 161.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.7 m -104.31 106.41 16.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.936 0.894 . . . . 0.0 108.69 172.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.15 -26.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.325 1.05 . . . . 0.0 111.641 -176.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.19 65.68 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.901 1.28 . . . . 0.0 114.179 177.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -119.5 -35.79 3.48 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.322 1.449 . . . . 0.0 112.637 176.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.75 38.11 7.66 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.053 0.835 . . . . 0.0 112.012 -176.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -134.32 169.63 16.93 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.817 1.247 . . . . 0.0 111.663 179.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.37 153.94 26.5 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.888 1.275 . . . . 0.0 111.664 -177.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.6 m -132.55 131.37 41.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 162.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 p -143.81 127.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.399 1.08 . . . . 0.0 111.018 -170.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.7 m -100.05 127.94 46.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.382 1.473 . . . . 0.0 108.943 170.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -149.81 163.15 38.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.996 1.318 . . . . 0.0 112.316 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -87.79 107.6 16.49 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.126 1.37 . . . . 0.0 107.402 173.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 3.41 3.94 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.836 3.024 . . . . 0.0 113.192 -170.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -118.34 -30.92 5.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.925 1.29 . . . . 0.0 111.015 -175.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -77.88 -36.95 49.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.465 164.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -141.3 172.71 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.347 1.43 . . . . 0.0 112.299 178.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -141.96 -172.13 3.5 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.792 1.637 . . . . 0.0 110.371 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -50.88 -28.1 8.88 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.318 -0.864 . . . . 0.0 113.012 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.5 mt -46.23 -42.01 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.346 1.858 . . . . 0.0 113.045 174.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 m -65.19 -41.13 94.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.501 0.72 . . . . 0.0 111.881 -176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tt -93.09 -25.03 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -51.02 -56.06 14.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.818 2.047 . . . . 0.0 111.056 171.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.24 3.6 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.51 -56.06 2.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.157 0.983 . . . . 0.0 110.864 160.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.77 -41.34 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.859 1.209 . . . . 0.0 111.722 -171.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.8 67.3 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.451 0.568 . . . . 0.0 112.385 175.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.65 -26.89 50.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.84 1.256 . . . . 0.0 113.465 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.7 mt -66.21 -3.28 5.41 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.047 1.339 . . . . 0.0 113.192 164.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.33 -6.93 82.53 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.809 1.671 . . . . 0.0 113.768 -176.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -84.44 -171.92 3.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.204 1.401 . . . . 0.0 112.39 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -139.89 157.4 45.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.544 1.137 . . . . 0.0 110.493 -171.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -145.85 160.17 42.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.1 132.89 7.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.666 1.586 . . . . 0.0 113.084 175.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.97 113.74 6.98 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.474 1.909 . . . . 0.0 106.337 170.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.66 2.906 . . . . 0.0 113.337 -168.136 . . . . . . . . 0 0 . 1 stop_ save_